Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_001605.3(AARS1):c.1009G>A (p.Glu337Lys)	AARS1	E337K	not provided|Charcot-Marie-Tooth disease, type 2N	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2022)	no assertion criteria provided	VCV001323797	16	70302236	16	70268333	1323797	1314078		NC_000016.10:70268332:C:T
NM_001605.3(AARS1):c.211A>T (p.Asn71Tyr)	AARS1	N71Y	not provided|Charcot-Marie-Tooth disease, type 2N	Pathogenic(Last reviewed: Nov 3, 2021)	no assertion criteria provided	VCV000030155	16	70310991	16	70277088	30155	39111	rs387906792	NC_000016.10:70277087:T:A
NM_001605.3(AARS1):c.986G>A (p.Arg329His)	AARS1	R329H	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2N|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008466	16	70302259	16	70268356	8466	23505	rs267606621	NC_000016.10:70268355:C:T
NM_004208.4(AIFM1):c.422C>T (p.Thr141Ile)	AIFM1|RAB33A	T141I, T137I	Cowchock syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000732674	X	129281779	X	130147804	732674	745482	rs1603227409	NC_000023.11:130147803:G:A
NM_004208.4(AIFM1):c.1019T>C (p.Met340Thr)	AIFM1|RAB33A	M340T, M1T, M336T	Combined oxidative phosphorylation deficiency|Charcot-Marie-Tooth Neuropathy X|not provided|Cowchock syndrome|Foot dorsiflexor weakness|Pes planus|Sensorineural hearing loss disorder|Distal muscle weakness	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374094	X	129271109	X	130137134	374094	361080	rs1057518895	NC_000023.11:130137133:A:G
NM_004208.4(AIFM1):c.1478A>T (p.Glu493Val)	AIFM1|RAB33A	E493V, E154V, E489V	Cowchock syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039601	X	129265745	X	130131770	39601	48200	rs281864468	NC_000023.11:130131769:T:A
NM_015915.5(ATL1):c.1065C>A (p.Asn355Lys)	ATL1	N355K	Charcot-Marie-Tooth disease|Distal lower limb muscle weakness|Distal sensory impairment|Osteomyelitis leading to amputation due to slow healing fractures|Penetrating foot ulcers|Hereditary sensory neuropathy type 1D	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000030579	14	51089912	14	50623194	30579	39536	rs1555365597	NC_000014.9:50623193:C:A
NM_000052.7(ATP7A):c.4156C>T (p.Pro1386Ser)	ATP7A	P1386S, P1308S	Charcot-Marie-Tooth disease|Menkes kinky-hair syndrome|Distal spinal muscular atrophy, X-linked 3|Cutis laxa, X-linked|Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000011795	X	77300999	X	78045502	11795	26834	rs267606672	NC_000023.11:78045501:C:T
NM_001122955.4(BSCL2):c.538G>T (p.Glu180Ter)	BSCL2|HNRNPUL2-BSCL2	E180*, E116*	Encephalopathy, progressive, with or without lipodystrophy	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000143859	11	62462132	11	62694660	143859	153584	rs587777607	NC_000011.10:62694659:C:A
NM_001122955.4(BSCL2):c.757G>T (p.Glu253Ter)	BSCL2|HNRNPUL2-BSCL2	E189*, E253*	Charcot-Marie-Tooth disease, type 2|Congenital generalized lipodystrophy type 2	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000004546	11	62460143	11	62692671	4546	19585	rs137852975	NC_000011.10:62692670:C:A
NM_001122955.4(BSCL2):c.461C>T (p.Ser154Leu)	BSCL2|HNRNPUL2-BSCL2	S90L, S154L	Spastic paraplegia 17|Charcot-Marie-Tooth disease, type 2|Spastic paraplegia 17|Neuronopathy, distal hereditary motor, type 5A|not provided|Neuronopathy, distal hereditary motor, type 5C	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004544	11	62469965	11	62702493	4544	19583	rs137852973	NC_000011.10:62702492:G:A
NM_001122955.4(BSCL2):c.455A>G (p.Asn152Ser)	BSCL2|HNRNPUL2-BSCL2	N88S, N152S	Spastic paraplegia 17|Charcot-Marie-Tooth disease, type 2|Neuronopathy, distal hereditary motor, type 5A|not provided|not specified|Neuronopathy, distal hereditary motor, type 5C	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004543	11	62469971	11	62702499	4543	19582	rs137852972	NC_000011.10:62702498:T:C
NM_004715.5(CTDP1):c.863+389C>T	CTDP1		Charcot-Marie-Tooth disease|not provided|Congenital cataracts-facial dysmorphism-neuropathy syndrome	Pathogenic(Last reviewed: Jan 1, 2021)	criteria provided, single submitter	VCV000005301	18	77470825	18	79710825	5301	20340	rs113994102	NC_000018.10:79710824:C:T
NM_006736.6(DNAJB2):c.352+1G>A	DNAJB2		Spinal muscular atrophy, distal, autosomal recessive, 5|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000217886	2	220146784	2	219282062	217886	214533	rs756614404	NC_000002.12:219282061:G:A
NM_001005361.3(DNM2):c.1105C>T (p.Arg369Trp)	DNM2	R369W	Charcot-Marie-Tooth disease|Myopathy, centronuclear, 1|Charcot-Marie-Tooth disease, dominant intermediate B|not provided|Centronuclear myopathy	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007280	19	10904508	19	10793832	7280	22319	rs121909090	NC_000019.10:10793831:C:T
NM_001130823.3(DNMT1):c.1532A>G (p.Tyr511Cys)	DNMT1	Y495C, Y511C, Y390C	Charcot-Marie-Tooth disease|not provided|Hereditary sensory neuropathy type IE	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029682	19	10265693	19	10155017	29682	38637	rs199473690	NC_000019.10:10155016:T:C
NM_001376.5(DYNC1H1):c.1739A>C (p.Glu580Ala)	DYNC1H1	E580A	Charcot-Marie-Tooth disease, axonal, type 2O	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001075692	14	102452301	14	101985964	1075692	1063045		NC_000014.9:101985963:A:C
NM_001376.5(DYNC1H1):c.1678G>A (p.Val560Met)	DYNC1H1	V560M	Charcot-Marie-Tooth disease, axonal, type 2O	Pathogenic(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000844512	14	102452240	14	101985903	844512	841021	rs2047931446	NC_000014.9:101985902:G:A
NM_001376.5(DYNC1H1):c.6994C>T (p.Arg2332Cys)	DYNC1H1	R2332C	Inborn genetic diseases|Seizures|Microcephaly|Delayed gross motor development|Delayed speech and language development|Global developmental delay|Charcot-Marie-Tooth disease, axonal, type 2O	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374190	14	102478787	14	102012450	374190	360957	rs1057518961	NC_000014.9:102012449:C:T
NM_001376.5(DYNC1H1):c.2327C>T (p.Pro776Leu)	DYNC1H1	P776L	not provided|Charcot-Marie-Tooth disease, axonal, type 2O|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant	Pathogenic(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372934	14	102452889	14	101986552	372934	360017	rs1057518083	NC_000014.9:101986551:C:T
NM_001376.5(DYNC1H1):c.1792C>T (p.Arg598Cys)	DYNC1H1	R598C	Inborn genetic diseases|not provided|Hereditary motor and sensory neuropathy|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|Mental retardation, autosomal dominant 13	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139652	14	102452354	14	101986017	139652	143271	rs587780564	NC_000014.9:101986016:C:T
NM_001376.5(DYNC1H1):c.10031G>A (p.Arg3344Gln)	DYNC1H1	R3344Q	Mental retardation, autosomal dominant 13|Charcot-Marie-Tooth disease, axonal, type 2O|Lissencephaly|Intellectual disability	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV000055855	14	102498756	14	102032419	55855	70509	rs397509412	NC_000014.9:102032418:G:A
NM_001376.5(DYNC1H1):c.917A>G (p.His306Arg)	DYNC1H1	H306R	not provided|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030029	14	102446843	14	101980506	30029	38984	rs387906738	NC_000014.9:101980505:A:G
NM_000399.5(EGR2):c.1142G>T (p.Arg381Leu)	EGR2	R331L, R381L	Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV001075624	10	64573256	10	62813496	1075624	1061937		NC_000010.11:62813495:C:A
NM_000399.5(EGR2):c.1141C>T (p.Arg381Cys)	EGR2	R381C, R331C	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000637524	10	64573257	10	62813497	637524	625202	rs1589080524	NC_000010.11:62813496:G:A
NM_000399.5(EGR2):c.1066G>A (p.Glu356Lys)	EGR2	E356K, E306K	Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000577101	10	64573332	10	62813572	577101	563802	rs751448371	NC_000010.11:62813571:C:T
NM_000399.5(EGR2):c.1226G>A (p.Arg409Gln)	EGR2	R409Q, R359Q	Charcot-Marie-Tooth disease, type I|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219844	10	64573172	10	62813412	219844	221982	rs864622273	NC_000010.11:62813411:C:T
NM_000399.5(EGR2):c.1142G>A (p.Arg381His)	EGR2	R381H, R331H	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 1d	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041008	10	64573256	10	62813496	41008	49430	rs281865137	NC_000010.11:62813495:C:T
NM_000399.5(EGR2):c.1234G>A (p.Glu412Lys)	EGR2	E412K, E362K	Dejerine-sottas neuropathy, autosomal dominant|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 27, 2019)	criteria provided, single submitter	VCV000016753	10	64573164	10	62813404	16753	31792	rs121434563	NC_000010.11:62813403:C:T
NM_000399.5(EGR2):c.1075C>T (p.Arg359Trp)	EGR2	R359W, R309W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1d|Dejerine-sottas neuropathy, autosomal dominant|Dejerine-Sottas disease	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016752	10	64573323	10	62813563	16752	31791	rs104894161	NC_000010.11:62813562:G:A
NM_000399.5(EGR2):c.1225C>T (p.Arg409Trp)	EGR2	R409W, R359W	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1d	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000016750	10	64573173	10	62813413	16750	31789	rs104894159	NC_000010.11:62813412:G:A
NM_003640.5(ELP1):c.2087G>C (p.Arg696Pro)	ELP1	R696P, R347P, R582P	Charcot-Marie-Tooth disease|Familial dysautonomia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006086	9	111662583	9	108900303	6086	21125	rs137853022	NC_000009.12:108900302:C:G
NM_003640.5(ELP1):c.2204+6T>C	ELP1		Familial dysautonomia|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006085	9	111662096	9	108899816	6085	21124	rs111033171	NC_000009.12:108899815:A:G
NM_001370298.3(FGD4):c.1304T>G (p.Met435Arg)	FGD4	M298R, M383R, M50R, M205R, M114R, M435R	Charcot-Marie-Tooth disease, type 4H|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000038445	12	32755151	12	32602217	38445	47004	rs63749871	NC_000012.12:32602216:T:G
NM_001370298.3(FGD4):c.1234C>T (p.Arg412Ter)	FGD4	R275*, R360*, R182*, R27*, R91*, R412*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000001016	12	32754344	12	32601410	1016	16055	rs118203974	NC_000012.12:32601409:C:T
NM_001370298.3(FGD4):c.2167G>T (p.Gly723Ter)	FGD4	G586*, G671*, G242*, G338*, G402*, G493*, G723*	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001014	12	32778708	12	32625774	1014	16053	rs118203973	NC_000012.12:32625773:G:T
FGD4, 893T-G	FGD4		Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001012					1012	16051		
NM_001370298.3(FGD4):c.1081C>T (p.Arg361Ter)	FGD4	R224*, R309*, R40*, R131*, R361*	Charcot-Marie-Tooth disease, type 4H|not provided	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000001011	12	32751500	12	32598566	1011	16050	rs118203972	NC_000012.12:32598565:C:T
NM_014845.6(FIG4):c.290-2A>G	FIG4		Yunis-Varon syndrome|Polymicrogyria, bilateral temporooccipital|Charcot-Marie-Tooth disease, type 4J	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638361	6	110048310	6	109727107	638361	626307	rs587777715	NC_000006.12:109727106:A:G
NM_014845.6(FIG4):c.2467C>T (p.Gln823Ter)	FIG4	Q823*	Charcot-Marie-Tooth disease, type 4J|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease|Yunis-Varon syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447336	6	110117975	6	109796772	447336	440905	rs745790694	NC_000006.12:109796771:C:T
NM_014845.6(FIG4):c.737G>A (p.Trp246Ter)	FIG4	W246*	not provided|Charcot-Marie-Tooth disease type 4|Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease, type 4J|Yunis-Varon syndrome|Polymicrogyria, bilateral temporooccipital	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420149	6	110059618	6	109738415	420149	406786	rs776005417	NC_000006.12:109738414:G:A
NM_002047.4(GARS1):c.1031+1G>A	GARS1		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637502	7	30651862	7	30612246	637502	625744	rs1554338272	NC_000007.14:30612245:G:A
NM_002047.4(GARS1):c.794C>T (p.Ser265Phe)	GARS1	S265F, S211F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000476762	7	30649259	7	30609643	476762	457766	rs1554337974	NC_000007.14:30609642:C:T
NM_002047.4(GARS1):c.1000A>T (p.Ile334Phe)	GARS1	I334F, I280F	Distal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2D|not provided|Charcot-Marie-Tooth disease|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000476747	7	30651830	7	30612214	476747	457158	rs1554338260	NC_000007.14:30612213:A:T
NM_002047.4(GARS1):c.1415A>G (p.His472Arg)	GARS1	H472R, H418R	Charcot-Marie-Tooth disease, type 2|Distal spinal muscular atrophy|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000410314	7	30661064	7	30621448	410314	395634	rs1060502838	NC_000007.14:30621447:A:G
NM_002047.4(GARS1):c.548T>C (p.Leu183Pro)	GARS1	L129P, L183P	not provided|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000009205	7	30640795	7	30601179	9205	24244	rs137852644	NC_000007.14:30601178:T:C
NM_002047.4(GARS1):c.880G>C (p.Gly294Arg)	GARS1	G240R, G294R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease type 2D|not provided	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009204	7	30649345	7	30609729	9204	24243	rs137852643	NC_000007.14:30609728:G:C
NM_018972.4(GDAP1):c.1A>T (p.Met1Leu)	GDAP1	M1L	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637503	8	75262697	8	74350462	637503	625156	rs1474390668	NC_000008.11:74350461:A:T
NM_018972.4(GDAP1):c.311-1G>A	GDAP1		not provided|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000637452	8	75272371	8	74360136	637452	625748	rs1370011538	NC_000008.11:74360135:G:A
NM_018972.4(GDAP1):c.767A>G (p.His256Arg)	GDAP1	H256R, H188R, H198R, H147R	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000618662	8	75276292	8	74364057	618662	609702	rs1476856429	NC_000008.11:74364056:A:G
NM_018972.4(GDAP1):c.112C>T (p.Gln38Ter)	GDAP1	Q38*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4A	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000569560	8	75262808	8	74350573	569560	565215	rs761035569	NC_000008.11:74350572:C:T
NM_018972.4(GDAP1):c.571C>T (p.Arg191Ter)	GDAP1	R191*, R123*, R133*, R82*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV000535790	8	75274205	8	74361970	535790	524304	rs1554547986	NC_000008.11:74361969:C:T
NM_018972.4(GDAP1):c.929G>A (p.Arg310Gln)	GDAP1	R310Q, R201Q, R252Q, R242Q	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449535	8	75276454	8	74364219	449535	444306	rs1323153568	NC_000008.11:74364218:G:A
NM_018972.4(GDAP1):c.458C>T (p.Pro153Leu)	GDAP1	P153L, P44L, P85L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000406135	8	75272519	8	74360284	406135	396265	rs538412810	NC_000008.11:74360283:C:T
NM_018972.4(GDAP1):c.769C>T (p.Arg257Ter)	GDAP1	R257*, R199*, R148*, R189*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A|not provided|Charcot-Marie-Tooth disease, recessive intermediate A	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245608	8	75276294	8	74364059	245608	244526	rs770501034	NC_000008.11:74364058:C:T
NM_018972.4(GDAP1):c.579+1G>A	GDAP1		not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: May 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220379	8	75274214	8	74361979	220379	221768	rs864622501	NC_000008.11:74361978:G:A
NM_018972.4(GDAP1):c.373C>T (p.Arg125Ter)	GDAP1	R125*, R16*, R57*	not provided|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, recessive intermediate A	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217229	8	75272434	8	74360199	217229	213815	rs745663149	NC_000008.11:74360198:C:T
NM_018972.4(GDAP1):c.821C>T (p.Pro274Leu)	GDAP1	P274L, P216L, P165L, P206L	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Aug 9, 2011)	no assertion criteria provided	VCV000050559	8	75276346	8	74364111	50559	59597	rs397515443	NC_000008.11:74364110:C:T
NM_018972.4(GDAP1):c.368A>G (p.His123Arg)	GDAP1	H123R, H55R, H14R	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000050558	8	75272429	8	74360194	50558	59596	rs397515442	NC_000008.11:74360193:A:G
NM_018972.4(GDAP1):c.467C>G (p.Ala156Gly)	GDAP1	A156G, A47G, A88G	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Aug 9, 2011)	no assertion criteria provided	VCV000050557	8	75272528	8	74360293	50557	59595	rs397515441	NC_000008.11:74360292:C:G
NM_018972.4(GDAP1):c.347T>G (p.Met116Arg)	GDAP1	M116R, M48R, M7R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A|not provided	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000038411	8	75272408	8	74360173	38411	46970	rs281865060	NC_000008.11:74360172:T:G
NM_018972.4(GDAP1):c.678A>T (p.Arg226Ser)	GDAP1	R226S, R117S, R168S, R158S	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000004204	8	75275272	8	74363037	4204	19243	rs267606842	NC_000008.11:74363036:A:T
NM_018972.4(GDAP1):c.719G>A (p.Cys240Tyr)	GDAP1	C240Y, C131Y, C182Y, C172Y	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000004203	8	75276244	8	74364009	4203	19242	rs121908115	NC_000008.11:74364008:G:A
NM_018972.4(GDAP1):c.692C>T (p.Pro231Leu)	GDAP1	P231L, P122L, P173L, P163L	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, type 4A	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004202	8	75275286	8	74363051	4202	19241	rs121908114	NC_000008.11:74363050:C:T
NM_018972.4(GDAP1):c.652C>G (p.Gln218Glu)	GDAP1	Q218E, Q160E, Q109E, Q150E	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000004201	8	75275246	8	74363011	4201	19240	rs121908113	NC_000008.11:74363010:C:G
NM_018972.4(GDAP1):c.715C>T (p.Leu239Phe)	GDAP1	L239F, L181F, L171F, L130F	Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, recessive intermediate A|Peripheral axonal neuropathy|Sensory neuropathy|Polyneuropathy|Elevated circulating creatine kinase concentration|Elevated circulating alkaline phosphatase concentration|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type 4A|GDAP1-Related Disorders	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004200	8	75276240	8	74364005	4200	19239	rs104894080	NC_000008.11:74364004:C:T
NM_018972.4(GDAP1):c.469A>C (p.Thr157Pro)	GDAP1	T157P, T48P, T89P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000004199	8	75272530	8	74360295	4199	19238	rs104894079	NC_000008.11:74360294:A:C
NM_018972.4(GDAP1):c.358C>T (p.Arg120Trp)	GDAP1	R120W, R11W, R52W	not provided|Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|none provided|Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004198	8	75272419	8	74360184	4198	19237	rs104894078	NC_000008.11:74360183:C:T
NM_018972.4(GDAP1):c.487C>T (p.Gln163Ter)	GDAP1	Q163*, Q105*, Q54*, Q95*	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type 4A|Neuropathy, axonal, with vocal cord paresis, autosomal recessive	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004193	8	75274121	8	74361886	4193	19232	rs104894077	NC_000008.11:74361885:C:T
NM_018972.4(GDAP1):c.581C>G (p.Ser194Ter)	GDAP1	S194*, S126*, S136*, S85*	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|not provided|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004191	8	75275175	8	74362940	4191	19230	rs104894075	NC_000008.11:74362939:C:G
NM_000334.4(SCN4A):c.2111C>T (p.Thr704Met)	GH-LCR|SCN4A	T704M	Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis, type 2|Hypokalemic periodic paralysis 1|Congenital myasthenic syndrome, acetazolamide-responsive|Paramyotonia congenita of von Eulenburg|Potassium-aggravated myotonia|not provided|Paramyotonia congenita/hyperkalemic periodic paralysis|Familial hyperkalemic periodic paralysis|Sotos syndrome 1	Pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005896	17	62034787	17	63957427	5896	20935	rs80338957	NC_000017.11:63957426:G:A
NM_000166.6(GJB1):c.47A>T (p.His16Leu)	GJB1	H16L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000637615	X	70443604	X	71223754	637615	625463	rs1602348610	NC_000023.11:71223753:A:T
NM_000166.6(GJB1):c.191G>A (p.Cys64Tyr)	GJB1	C64Y	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV000637608	X	70443748	X	71223898	637608	625522	rs1602348897	NC_000023.11:71223897:G:A
NM_000166.6(GJB1):c.68T>C (p.Val23Ala)	GJB1	V23A	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000637585	X	70443625	X	71223775	637585	625474	rs1602348650	NC_000023.11:71223774:T:C
NM_000166.6(GJB1):c.281A>G (p.His94Arg)	GJB1	H94R	Charcot-Marie-Tooth Neuropathy X Type 1|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000637565	X	70443838	X	71223988	637565	625569	rs1602349095	NC_000023.11:71223987:A:G
NM_000166.6(GJB1):c.238C>A (p.Gln80Lys)	GJB1	Q80K	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 1, 2020)	criteria provided, single submitter	VCV000637563	X	70443795	X	71223945	637563	625541	rs1602348981	NC_000023.11:71223944:C:A
NM_000166.6(GJB1):c.195T>G (p.Tyr65Ter)	GJB1	Y65*	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000637562	X	70443752	X	71223902	637562	625526	rs1602348907	NC_000023.11:71223901:T:G
NM_000166.6(GJB1):c.518G>T (p.Cys173Phe)	GJB1	C173F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000637236	X	70444075	X	71224225	637236	625645	rs1602349535	NC_000023.11:71224224:G:T
NM_000166.6(GJB1):c.381C>G (p.Ile127Met)	GJB1	I127M	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000637216	X	70443938	X	71224088	637216	625589	rs1602349264	NC_000023.11:71224087:C:G
NM_000166.6(GJB1):c.89T>C (p.Ile30Thr)	GJB1	I30T	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000637215	X	70443646	X	71223796	637215	625484	rs104894817	NC_000023.11:71223795:T:C
NM_000166.6(GJB1):c.119C>T (p.Ala40Val)	GJB1	A40V	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000637200	X	70443676	X	71223826	637200	625499	rs1602348786	NC_000023.11:71223825:C:T
NM_000166.6(GJB1):c.260C>T (p.Pro87Leu)	GJB1	P87L	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000637139	X	70443817	X	71223967	637139	625557	rs1602349021	NC_000023.11:71223966:C:T
NM_000166.6(GJB1):c.238C>T (p.Gln80Ter)	GJB1	Q80*	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000637135	X	70443795	X	71223945	637135	625542	rs1602348981	NC_000023.11:71223944:C:T
NM_000166.6(GJB1):c.633C>A (p.Tyr211Ter)	GJB1	Y211*	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000620115	X	70444190	X	71224340	620115	611955	rs1569215443	NC_000023.11:71224339:C:A
NM_000166.6(GJB1):c.100A>G (p.Met34Val)	GJB1	M34V	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000565409	X	70443657	X	71223807	565409	573989	rs1569215061	NC_000023.11:71223806:A:G
NM_000166.6(GJB1):c.8G>A (p.Trp3Ter)	GJB1	W3*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000543927	X	70443565	X	71223715	543927	534951	rs1555936989	NC_000023.11:71223714:G:A
NM_000166.6(GJB1):c.491G>A (p.Arg164Gln)	GJB1	R164Q	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Dec 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000543920	X	70444048	X	71224198	543920	535194	rs1241595912	NC_000023.11:71224197:G:A
NM_000166.6(GJB1):c.77C>G (p.Ser26Trp)	GJB1	S26W	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000477604	X	70443634	X	71223784	477604	472198	rs587777876	NC_000023.11:71223783:C:G
NM_000166.6(GJB1):c.515C>T (p.Pro172Leu)	GJB1	P172L	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000477599	X	70444072	X	71224222	477599	471000	rs1555937218	NC_000023.11:71224221:C:T
NM_000166.6(GJB1):c.64C>T (p.Arg22Ter)	GJB1	R22*	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447441	X	70443621	X	71223771	447441	442441	rs1555937020	NC_000023.11:71223770:C:T
NM_000166.6(GJB1):c.622G>A (p.Glu208Lys)	GJB1	E208K	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447439	X	70444179	X	71224329	447439	442454	rs1555937270	NC_000023.11:71224328:G:A
NM_000166.6(GJB1):c.548G>A (p.Arg183His)	GJB1	R183H	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Mar 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000447435	X	70444105	X	71224255	447435	442450	rs1555937233	NC_000023.11:71224254:G:A
NM_000166.6(GJB1):c.478T>C (p.Tyr160His)	GJB1	Y160H	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447432	X	70444035	X	71224185	447432	442447	rs1555937197	NC_000023.11:71224184:T:C
NM_000166.6(GJB1):c.266T>C (p.Leu89Pro)	GJB1	L89P	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447428	X	70443823	X	71223973	447428	442443	rs1555937122	NC_000023.11:71223972:T:C
NM_000166.6(GJB1):c.566T>G (p.Val189Gly)	GJB1	V189G	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420023	X	70444123	X	71224273	420023	411472	rs1064794244	NC_000023.11:71224272:T:G
NM_000166.6(GJB1):c.65G>A (p.Arg22Gln)	GJB1	R22Q	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000406228	X	70443622	X	71223772	406228	404289	rs1060501002	NC_000023.11:71223771:G:A
NM_000166.6(GJB1):c.101T>C (p.Met34Thr)	GJB1	M34T	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000406224	X	70443658	X	71223808	406224	404290	rs1060500998	NC_000023.11:71223807:T:C
NM_000166.6(GJB1):c.643C>T (p.Arg215Trp)	GJB1	R215W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000246098	X	70444200	X	71224350	246098	245189	rs879254099	NC_000023.11:71224349:C:T
NM_000166.6(GJB1):c.239A>G (p.Gln80Arg)	GJB1	Q80R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000246096	X	70443796	X	71223946	246096	245182	rs879254097	NC_000023.11:71223945:A:G
NM_000166.6(GJB1):c.231G>A (p.Trp77Ter)	GJB1	W77*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000246095	X	70443788	X	71223938	246095	245181	rs879254096	NC_000023.11:71223937:G:A
NM_000166.6(GJB1):c.112G>A (p.Val38Met)	GJB1	V38M	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000245946	X	70443669	X	71223819	245946	245179	rs879254012	NC_000023.11:71223818:G:A
NM_000166.6(GJB1):c.282C>A (p.His94Gln)	GJB1	H94Q	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	VCV000245724	X	70443839	X	71223989	245724	245183	rs756000896	NC_000023.11:71223988:C:A
NM_000166.6(GJB1):c.541G>A (p.Val181Met)	GJB1	V181M	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000245705	X	70444098	X	71224248	245705	245188	rs879253909	NC_000023.11:71224247:G:A
NM_000166.6(GJB1):c.208C>G (p.Pro70Ala)	GJB1	P70A	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237122	X	70443765	X	71223915	237122	243822	rs878853697	NC_000023.11:71223914:C:G
NM_000166.6(GJB1):c.556G>T (p.Glu186Ter)	GJB1	E186*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000234612	X	70444113	X	71224263	234612	232162	rs116840821	NC_000023.11:71224262:G:T
NM_000166.6(GJB1):c.224G>A (p.Arg75Gln)	GJB1	R75Q	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217167	X	70443781	X	71223931	217167	213892	rs863224972	NC_000023.11:71223930:G:A
NM_000166.6(GJB1):c.-103C>T	GJB1		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Feb 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217166	X	70443099	X	71223249	217166	213890	rs863224971	NC_000023.11:71223248:C:T
NM_000166.6(GJB1):c.547C>T (p.Arg183Cys)	GJB1	R183C	Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000216039	X	70444104	X	71224254	216039	213502	rs863224471	NC_000023.11:71224253:C:T
NM_000166.6(GJB1):c.305A>G (p.Glu102Gly)	GJB1	E102G	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216038	X	70443862	X	71224012	216038	213501	rs779696968	NC_000023.11:71224011:A:G
NM_000166.6(GJB1):c.83T>A (p.Ile28Asn)	GJB1	I28N	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000215983	X	70443640	X	71223790	215983	213498	rs768834663	NC_000023.11:71223789:T:A
NM_000166.6(GJB1):c.116C>T (p.Ala39Val)	GJB1	A39V	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	VCV000188136	X	70443673	X	71223823	188136	186290	rs786204095	NC_000023.11:71223822:C:T
NM_000166.6(GJB1):c.556G>A (p.Glu186Lys)	GJB1	E186K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000021086	X	70444113	X	71224263	21086	33938	rs116840821	NC_000023.11:71224262:G:A
NM_000166.6(GJB1):c.43C>T (p.Arg15Trp)	GJB1	R15W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021084	X	70443600	X	71223750	21084	33936	rs116840815	NC_000023.11:71223749:C:T
NM_000166.6(GJB1):c.223C>T (p.Arg75Trp)	GJB1	R75W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Jan 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000021082	X	70443780	X	71223930	21082	33934	rs116840819	NC_000023.11:71223929:C:T
NM_000166.6(GJB1):c.187G>A (p.Val63Ile)	GJB1	V63I	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021081	X	70443744	X	71223894	21081	33933	rs116840818	NC_000023.11:71223893:G:A
NM_000166.6(GJB1):c.407T>C (p.Val136Ala)	GJB1	V136A	Charcot-Marie-Tooth Neuropathy X Type 1|Dejerine-Sottas disease	Pathogenic(Last reviewed: Apr 15, 2010)	no assertion criteria provided	VCV000010451	X	70443964	X	71224114	10451	25490	rs104894826	NC_000023.11:71224113:T:C
NM_000166.6(GJB1):c.164C>T (p.Thr55Ile)	GJB1	T55I	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000010446	X	70443721	X	71223871	10446	25485	rs104894824	NC_000023.11:71223870:C:T
NM_000166.6(GJB1):c.283G>A (p.Val95Met)	GJB1	V95M	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X Type 1|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000010441	X	70443840	X	71223990	10441	25480	rs104894821	NC_000023.11:71223989:G:A
NM_000166.6(GJB1):c.415G>A (p.Val139Met)	GJB1	V139M	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV000010433	X	70443972	X	71224122	10433	25472	rs104894812	NC_000023.11:71224121:G:A
NM_002109.6(HARS1):c.464T>G (p.Val155Gly)	HARS1	V155G, V115G, V126G	Charcot-Marie-Tooth disease, axonal, type 2w|Usher syndrome, type 3B	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000446299	5	140058645	5	140679060	446299	439703	rs1239341211	NC_000005.10:140679059:A:C
NM_005340.7(HINT1):c.368G>A (p.Trp123Ter)	HINT1	W123*	Charcot-Marie-Tooth disease|Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000637254	5	130495153	5	131159460	637254	625108	rs1580682390	NC_000005.10:131159459:C:T
NM_005340.7(HINT1):c.316C>T (p.Gln106Ter)	HINT1	Q106*	not provided|Charcot-Marie-Tooth disease|Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000637252	5	130495205	5	131159512	637252	625110	rs1028404937	NC_000005.10:131159511:G:A
NM_001122955.4(BSCL2):c.985C>T (p.Arg329Ter)	HNRNPUL2-BSCL2|BSCL2	R329*	Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease, type 2|Encephalopathy, progressive, with or without lipodystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143858	11	62458772	11	62691300	143858	153583	rs587777606	NC_000011.10:62691299:G:A
NM_001540.5(HSPB1):c.544C>G (p.Pro182Ala)	HSPB1	P182A	Charcot-Marie-Tooth disease axonal type 2F	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000946496	7	75933416	7	76304099	946496	924907	rs104894020	NC_000007.14:76304098:C:G
NM_001540.5(HSPB1):c.153G>A (p.Trp51Ter)	HSPB1	W51*	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000917325	7	75932182	7	76302865	917325	905200	rs769118115	NC_000007.14:76302864:G:A
NM_001540.5(HSPB1):c.250G>A (p.Gly84Arg)	HSPB1	G84R	Charcot-Marie-Tooth disease|not provided|HSPB1-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000632006	7	75932279	7	76302962	632006	620269	rs770272088	NC_000007.14:76302961:G:A
NM_001540.5(HSPB1):c.116C>T (p.Pro39Leu)	HSPB1	P39L	HSPB1-related axonal neuropathies|Charcot-Marie-Tooth disease axonal type 2F|Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000533814	7	75932145	7	76302828	533814	522820	rs557327165	NC_000007.14:76302827:C:T
NM_001540.5(HSPB1):c.404C>A (p.Ser135Tyr)	HSPB1	S135Y	Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533813	7	75933158	7	76303841	533813	523269	rs28939680	NC_000007.14:76303840:C:A
NM_001540.5(HSPB1):c.539C>T (p.Thr180Ile)	HSPB1	T180I	not provided|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447531	7	75933411	7	76304094	447531	441146	rs1422978230	NC_000007.14:76304093:C:T
NM_001540.5(HSPB1):c.416C>T (p.Thr139Met)	HSPB1	T139M	not provided|Charcot-Marie-Tooth disease axonal type 2F|none provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000421350	7	75933170	7	76303853	421350	407260	rs1064795077	NC_000007.14:76303852:C:T
NM_001540.5(HSPB1):c.250G>C (p.Gly84Arg)	HSPB1	G84R	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220419	7	75932279	7	76302962	220419	221739	rs770272088	NC_000007.14:76302961:G:C
NM_001540.5(HSPB1):c.523C>T (p.Gln175Ter)	HSPB1	Q175*	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217231	7	75933395	7	76304078	217231	213814	rs863225023	NC_000007.14:76304077:C:T
NM_001540.5(HSPB1):c.407G>T (p.Arg136Leu)	HSPB1	R136L	Inborn genetic diseases|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217230	7	75933161	7	76303844	217230	213813	rs863225022	NC_000007.14:76303843:G:T
NM_001540.5(HSPB1):c.380G>T (p.Arg127Leu)	HSPB1	R127L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000157529	7	75933134	7	76303817	157529	167391	rs587781250	NC_000007.14:76303816:G:T
NM_001540.5(HSPB1):c.418C>G (p.Arg140Gly)	HSPB1	R140G	Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease axonal type 2F|HSPB1-related axonal neuropathies|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007484	7	75933172	7	76303855	7484	22523	rs121909112	NC_000007.14:76303854:C:G
NM_001540.5(HSPB1):c.544C>T (p.Pro182Ser)	HSPB1	P182S	Charcot-Marie-Tooth disease axonal type 2F|Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000007483	7	75933416	7	76304099	7483	22522	rs104894020	NC_000007.14:76304098:C:T
NM_001540.5(HSPB1):c.406C>T (p.Arg136Trp)	HSPB1	R136W	Charcot-Marie-Tooth disease axonal type 2F	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000007482	7	75933160	7	76303843	7482	22521	rs28939681	NC_000007.14:76303842:C:T
NM_001540.5(HSPB1):c.379C>T (p.Arg127Trp)	HSPB1	R127W	Charcot-Marie-Tooth disease axonal type 2F|not provided|Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Jul 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007479	7	75933133	7	76303816	7479	22518	rs29001571	NC_000007.14:76303815:C:T
NM_001540.5(HSPB1):c.404C>T (p.Ser135Phe)	HSPB1	S135F	Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000007478	7	75933158	7	76303841	7478	22517	rs28939680	NC_000007.14:76303840:C:T
NM_014365.3(HSPB8):c.421A>G (p.Lys141Glu)	HSPB8		Distal hereditary motor neuronopathy type 2A|Charcot-Marie-Tooth disease, type 2L|not provided	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002618	12	119624883	12	119187078	2618	17657	rs104894351	NC_000012.12:119187077:A:G
NM_002180.3(IGHMBP2):c.2362C>T (p.Arg788Ter)	IGHMBP2	R788*	Autosomal dominant distal hereditary motor neuropathy|Charcot-Marie-Tooth disease|not provided|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV000637262	11	68704310	11	68936842	637262	625255	rs199839840	NC_000011.10:68936841:C:T
NM_002180.3(IGHMBP2):c.1708C>T (p.Arg570Ter)	IGHMBP2	R570*	Charcot-Marie-Tooth disease|Spinal muscular atrophy, distal, autosomal recessive, 1|Distal spinal muscular atrophy|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561032	11	68702842	11	68935374	561032	552154	rs1000091588	NC_000011.10:68935373:C:T
NM_002180.3(IGHMBP2):c.439C>T (p.Arg147Ter)	IGHMBP2	R147*	Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Autosomal dominant distal hereditary motor neuropathy|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521206	11	68675795	11	68908327	521206	511936	rs1324667543	NC_000011.10:68908326:C:T
NM_002180.3(IGHMBP2):c.1813C>T (p.Arg605Ter)	IGHMBP2	R605*	Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Sep 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000488694	11	68703761	11	68936293	488694	482001	rs991227431	NC_000011.10:68936292:C:T
NM_002180.3(IGHMBP2):c.1082T>C (p.Leu361Pro)	IGHMBP2	L361P	Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S|not provided|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000245627	11	68696672	11	68929204	245627	244678	rs201060167	NC_000011.10:68929203:T:C
NM_002180.3(IGHMBP2):c.1488C>A (p.Cys496Ter)	IGHMBP2	C496*	Charcot-Marie-Tooth disease|not provided|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000234316	11	68701332	11	68933864	234316	231807	rs145226920	NC_000011.10:68933863:C:A
NM_022489.4(INF2):c.395T>C (p.Leu132Pro)	INF2	L132P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate E|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV000637706	14	105169445	14	104703108	637706	625305	rs387907038	NC_000014.9:104703107:T:C
NM_022489.4(INF2):c.341G>A (p.Gly114Asp)	INF2	G114D	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate E|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV000637704	14	105168043	14	104701706	637704	625304	rs1595164091	NC_000014.9:104701705:G:A
NM_022489.4(INF2):c.170T>C (p.Leu57Pro)	INF2	L57P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate E|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000637700	14	105167872	14	104701535	637700	625294	rs1595163736	NC_000014.9:104701534:T:C
NM_022489.4(INF2):c.640C>T (p.Arg214Cys)	INF2	R214C	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate E|Focal segmental glomerulosclerosis 5|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000635443	14	105169764	14	104703427	635443	623317	rs912928648	NC_000014.9:104703426:C:T
NM_022489.4(INF2):c.550G>A (p.Glu184Lys)	INF2	E184K	Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease, dominant intermediate E|Charcot-Marie-Tooth disease|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000599128	14	105169674	14	104703337	599128	590307	rs1566778676	NC_000014.9:104703336:G:A
NM_022489.4(INF2):c.658G>A (p.Glu220Lys)	INF2	E220K	Focal segmental glomerulosclerosis 5|not provided|Charcot-Marie-Tooth disease|Hypertensive disorder|Focal segmental glomerulosclerosis|Renal insufficiency|Proteinuria	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523533	14	105169782	14	104703445	523533	514037	rs530391015	NC_000014.9:104703444:G:A
NM_000214.3(JAG1):c.1948T>C (p.Ser650Pro)	JAG1		CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2HH	Pathogenic(Last reviewed: Oct 21, 2021)	no assertion criteria provided	VCV001300242	20	10626670	20	10646022	1300242	1290527		NC_000020.11:10646021:A:G
NM_000214.3(JAG1):c.1731C>G (p.Ser577Arg)	JAG1		CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2HH	Pathogenic(Last reviewed: Feb 26, 2021)	criteria provided, single submitter	VCV001300241	20	10627741	20	10647093	1300241	1290526		NC_000020.11:10647092:G:C
NM_001136472.2(LITAF):c.332C>G (p.Ala111Gly)	LITAF	A111G	Charcot-Marie-Tooth disease, type 1C|Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000041229	16	11647434	16	11553578	41229	49653	rs281865134	NC_000016.10:11553577:G:C
NM_001136472.2(LITAF):c.334G>A (p.Gly112Ser)	LITAF	G112S	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 1C	Pathogenic(Last reviewed: Feb 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006057	16	11647432	16	11553576	6057	21096	rs104894519	NC_000016.10:11553575:C:T
NM_170707.4(LMNA):c.158A>G (p.Glu53Gly)	LMNA	E53G	not provided|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424915	1	156084867	1	156115076	424915	413249	rs60290646	NC_000001.11:156115075:A:G
NM_170707.4(LMNA):c.82C>T (p.Arg28Trp)	LMNA	R28W	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, single submitter	VCV000066946	1	156084791	1	156115000	66946	77843	rs59914820	NC_000001.11:156114999:C:T
NM_170707.4(LMNA):c.1609-3C>G	LMNA		Primary dilated cardiomyopathy|not provided|Charcot-Marie-Tooth disease|Dilated cardiomyopathy 1A|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066856	1	156107442	1	156137651	66856	77753	rs267607581	NC_000001.11:156137650:C:G
NM_170707.4(LMNA):c.1583C>A (p.Thr528Lys)	LMNA	T528K, T416K, T447K	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided|Hutchinson-Gilford syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066849	1	156106998	1	156137207	66849	77746	rs57629361	NC_000001.11:156137206:C:A
NM_170707.4(LMNA):c.1380+1G>A	LMNA		Charcot-Marie-Tooth disease, type 2|not provided|Hutchinson-Gilford syndrome|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Dilated cardiomyopathy 1A|Familial partial lipodystrophy 2|Charcot-Marie-Tooth disease type 2B1|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Mandibuloacral dysplasia with type A lipodystrophy|Congenital muscular dystrophy, LMNA-related	Pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066817	1	156106228	1	156136437	66817	77714	rs267607552	NC_000001.11:156136436:G:A
NM_170707.4(LMNA):c.11C>G (p.Pro4Arg)	LMNA	P4R	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000066795	1	156084720	1	156114929	66795	77692	rs267607620	NC_000001.11:156114928:C:G
NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp)	LMNA	R349W, R237W, R268W	Charcot-Marie-Tooth disease, type 2|not provided|Congenital muscular dystrophy, LMNA-related|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Charcot-Marie-Tooth disease type 2B1|Hutchinson-Gilford syndrome|Familial partial lipodystrophy 2|Monogenic diabetes	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066762	1	156105800	1	156136009	66762	77659	rs267607555	NC_000001.11:156136008:C:T
NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	LMNA	R335W, R223W, R254W	Left ventricular noncompaction|Arrhythmogenic right ventricular cardiomyopathy|Heart-hand syndrome, Slovenian type|Primary dilated cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Familial partial lipodystrophy 2|Dilated cardiomyopathy 1A|Hutchinson-Gilford syndrome|Congenital muscular dystrophy, LMNA-related|Lethal tight skin contracture syndrome|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Charcot-Marie-Tooth disease type 2B1|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Heart-hand syndrome, Slovenian type|Mandibuloacral dysplasia with type A lipodystrophy|Primary dilated cardiomyopathy|Laminopathy|Charcot-Marie-Tooth disease, type 2|Dilated cardiomyopathy 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000036473	1	156105758	1	156135967	36473	45135	rs386134243	NC_000001.11:156135966:C:T
NM_170707.4(LMNA):c.1072G>A (p.Glu358Lys)	LMNA	E358K, E246K, E277K	Muscular dystrophy|not provided|Congenital muscular dystrophy, LMNA-related|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy	Pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014525	1	156105827	1	156136036	14525	29564	rs60458016	NC_000001.11:156136035:G:A
NM_170707.4(LMNA):c.745C>T (p.Arg249Trp)	LMNA	R249W, R137W, R168W	Charcot-Marie-Tooth disease, type 2|Congenital muscular dystrophy, LMNA-related|not provided|Benign scapuloperoneal muscular dystrophy with cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014524	1	156104701	1	156134910	14524	29563	rs121912496	NC_000001.11:156134909:C:T
NM_170707.4(LMNA):c.1824C>T (p.Gly608=)	LMNA		not provided|Hutchinson-Gilford syndrome|Primary dilated cardiomyopathy|Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease, type 2|Lethal tight skin contracture syndrome	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014500	1	156108404	1	156138613	14500	29539	rs58596362	NC_000001.11:156138612:C:T
NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp)	LMNA	R482W, R401W, R370W	Charcot-Marie-Tooth disease|Inborn genetic diseases|Familial partial lipodystrophy 2|Familial partial lipodystrophy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014489	1	156106775	1	156136984	14489	29528	rs57920071	NC_000001.11:156136983:C:T
NM_170707.4(LMNA):c.398G>T (p.Arg133Leu)	LMNA	R133L, R21L, R52L	Charcot-Marie-Tooth disease, type 2|not provided|Hutchinson-Gilford progeria syndrome, childhood-onset|Familial partial lipodystrophy 2	Pathogenic(Last reviewed: Jul 5, 2020)	criteria provided, single submitter	VCV000014488	1	156100449	1	156130658	14488	29527	rs60864230	NC_000001.11:156130657:G:T
NM_001005373.4(LRSAM1):c.1144C>T (p.Arg382Ter)	LRSAM1	R119*, R382*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001076638	9	130245284	9	127483005	1076638	1061544		NC_000009.12:127483004:C:T
NM_001005373.4(LRSAM1):c.988C>T (p.Gln330Ter)	LRSAM1	Q330*, Q67*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Sep 4, 2020)	criteria provided, single submitter	VCV001073788	9	130242202	9	127479923	1073788	1061543		NC_000009.12:127479922:C:T
NM_001005373.4(LRSAM1):c.636C>G (p.Tyr212Ter)	LRSAM1	Y212*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000540003	9	130236096	9	127473817	540003	524474	rs1345228128	NC_000009.12:127473816:C:G
NM_001005373.4(LRSAM1):c.2080T>C (p.Cys694Arg)	LRSAM1	C694R, C667R, C431R, C661R	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000408267	9	130265086	9	127502807	408267	396678	rs759312530	NC_000009.12:127502806:T:C
NM_001005373.4(LRSAM1):c.2081G>A (p.Cys694Tyr)	LRSAM1	C694Y, C667Y, C431Y, C661Y	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 8, 2016)	no assertion criteria provided	VCV000268046	9	130265087	9	127502808	268046	263456	rs886041051	NC_000009.12:127502807:G:A
NM_001005373.4(LRSAM1):c.2068T>C (p.Cys690Arg)	LRSAM1	C690R, C663R, C427R, C657R	not provided|Charcot-Marie-Tooth disease type 2P	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000242907	9	130265074	9	127502795	242907	244017	rs879253755	NC_000009.12:127502794:T:C
NM_001005373.4(LRSAM1):c.1279C>T (p.Arg427Ter)	LRSAM1	R427*, R164*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000241836	9	130249974	9	127487695	241836	240444	rs138226428	NC_000009.12:127487694:C:T
NM_001005373.4(LRSAM1):c.1913-1G>A	LRSAM1		Charcot-Marie-Tooth disease type 2P|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000204301	9	130263288	9	127501009	204301	200697	rs756880678	NC_000009.12:127501008:G:A
NM_001005373.4(LRSAM1):c.1914G>A (p.Glu638=)	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Aug 26, 2010)	no assertion criteria provided	VCV000030859	9	130263290	9	127501011	30859	39816	rs387907032	NC_000009.12:127501010:G:A
NM_006767.4(LZTR1):c.850C>T (p.Arg284Cys)	LZTR1	R284C	Schwannomatosis 2|Noonan syndrome 10|not provided|Noonan syndrome 10	Pathogenic(Last reviewed: Nov 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000209089	22	21345975	22	20991686	209089	205686	rs797045165	NC_000022.11:20991685:C:T
NM_014874.4(MFN2):c.922G>T (p.Glu308Ter)	MFN2	E308*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV000637744	1	12061563	1	12001506	637744	624932	rs1553143852	NC_000001.11:12001505:G:T
NM_014874.4(MFN2):c.692C>T (p.Ser231Phe)	MFN2	S231F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000637741	1	12058919	1	11998862	637741	624917	rs1569842714	NC_000001.11:11998861:C:T
NM_014874.4(MFN2):c.275T>C (p.Leu92Pro)	MFN2	L92P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000637730	1	12052711	1	11992654	637730	624892	rs1569816285	NC_000001.11:11992653:T:C
NM_014874.4(MFN2):c.475-1G>C	MFN2		Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000637718	1	12057353	1	11997296	637718	625724	rs1569834500	NC_000001.11:11997295:G:C
NM_014874.4(MFN2):c.280C>G (p.Arg94Gly)	MFN2	R94G	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000637495	1	12052716	1	11992659	637495	624894	rs119103263	NC_000001.11:11992658:C:G
NM_014874.4(MFN2):c.1081C>T (p.His361Tyr)	MFN2	H361Y	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000637315	1	12062081	1	12002024	637315	624937	rs1569854012	NC_000001.11:12002023:C:T
NM_014874.4(MFN2):c.2213C>T (p.Ala738Val)	MFN2	A738V	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, single submitter	VCV000637283	1	12071561	1	12011504	637283	624963	rs1569889919	NC_000001.11:12011503:C:T
NM_014874.4(MFN2):c.776G>T (p.Arg259Leu)	MFN2	R259L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000637279	1	12059112	1	11999055	637279	624925	rs755065651	NC_000001.11:11999054:G:T
NM_014874.4(MFN2):c.2037C>G (p.Tyr679Ter)	MFN2	Y679*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV000637064	1	12067274	1	12007217	637064	624958	rs1569871830	NC_000001.11:12007216:C:G
NM_014874.4(MFN2):c.1392+1G>A	MFN2		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637063	1	12064671	1	12004614	637063	625726	rs1569861708	NC_000001.11:12004613:G:A
NM_014874.4(MFN2):c.776G>A (p.Arg259His)	MFN2	R259H	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV000577496	1	12059112	1	11999055	577496	556905	rs755065651	NC_000001.11:11999054:G:A
NM_014874.4(MFN2):c.638T>C (p.Ile213Thr)	MFN2	I213T	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV000575481	1	12058865	1	11998808	575481	556615	rs1557524703	NC_000001.11:11998807:T:C
NM_014874.4(MFN2):c.2251C>T (p.Gln751Ter)	MFN2	Q751*	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000572169	1	12071599	1	12011542	572169	556909	rs1557539119	NC_000001.11:12011541:C:T
NM_014874.4(MFN2):c.1091G>C (p.Arg364Pro)	MFN2	R364P	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000572157	1	12062091	1	12002034	572157	558090	rs879254011	NC_000001.11:12002033:G:C
NM_014874.4(MFN2):c.313A>G (p.Thr105Ala)	MFN2	T105A	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, single submitter	VCV000543234	1	12056214	1	11996157	543234	515078	rs1553142428	NC_000001.11:11996156:A:G
NM_014874.4(MFN2):c.748C>T (p.Arg250Trp)	MFN2	R250W	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000543219	1	12059084	1	11999027	543219	515150	rs373107074	NC_000001.11:11999026:C:T
NM_014874.4(MFN2):c.493C>T (p.His165Tyr)	MFN2	H165Y	Charcot-Marie-Tooth disease, type 2|not specified|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439897	1	12057372	1	11997315	439897	433691	rs119103262	NC_000001.11:11997314:C:T
NM_014874.4(MFN2):c.1252C>T (p.Arg418Ter)	MFN2	R418*	not provided|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372790	1	12064140	1	12004083	372790	359204	rs1057517987	NC_000001.11:12004082:C:T
NM_014874.4(MFN2):c.1091G>A (p.Arg364Gln)	MFN2	R364Q	Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000245944	1	12062091	1	12002034	245944	244195	rs879254011	NC_000001.11:12002033:G:A
NM_014874.4(MFN2):c.1198C>T (p.Arg400Ter)	MFN2	R400*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000245768	1	12064086	1	12004029	245768	244198	rs879253939	NC_000001.11:12004028:C:T
NM_014874.4(MFN2):c.746C>T (p.Ser249Phe)	MFN2	S249F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000202171	1	12059082	1	11999025	202171	198602	rs794729198	NC_000001.11:11999024:C:T
NM_014874.4(MFN2):c.775C>T (p.Arg259Cys)	MFN2	R259C	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000155730	1	12059111	1	11999054	155730	165484	rs587777875	NC_000001.11:11999053:C:T
NM_014874.4(MFN2):c.1085C>T (p.Thr362Met)	MFN2	T362M	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030738	1	12062085	1	12002028	30738	39695	rs387906991	NC_000001.11:12002027:C:T
NM_014874.4(MFN2):c.310C>T (p.Arg104Trp)	MFN2	R104W	Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2A2A|Inborn genetic diseases|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002281	1	12052746	1	11992689	2281	17320	rs119103268	NC_000001.11:11992688:C:T
NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp)	MFN2	R707W	not provided|Peripheral axonal neuropathy|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Inborn genetic diseases|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A|MFN2-Related Disorders|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002280	1	12069698	1	12009641	2280	17319	rs119103267	NC_000001.11:12009640:C:T
NM_014874.4(MFN2):c.617C>T (p.Thr206Ile)	MFN2	T206I	Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000002279	1	12058844	1	11998787	2279	17318	rs119103266	NC_000001.11:11998786:C:T
NM_014874.4(MFN2):c.1090C>T (p.Arg364Trp)	MFN2	R364W	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease type 4|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002278	1	12062090	1	12002033	2278	17317	rs119103265	NC_000001.11:12002032:C:T
NM_014874.4(MFN2):c.280C>T (p.Arg94Trp)	MFN2	R94W	Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided|Microcephaly|Short stature|Failure to thrive|Abnormality of the dentition|Abnormal dental enamel morphology|Hyperpigmentation of the skin|Scarring|EMG abnormality|Decreased body weight|Scarring alopecia of scalp|Abnormal blistering of the skin|Nail dystrophy|Alopecia of scalp|Distal muscle weakness|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002276	1	12052716	1	11992659	2276	17315	rs119103263	NC_000001.11:11992658:C:T
NM_014874.4(MFN2):c.493C>G (p.His165Asp)	MFN2	H165D	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000002275	1	12057372	1	11997315	2275	17314	rs119103262	NC_000001.11:11997314:C:G
NM_014874.4(MFN2):c.751C>G (p.Pro251Ala)	MFN2	P251A	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic	criteria provided, single submitter	VCV000002272	1	12059087	1	11999030	2272	17311	rs28940295	NC_000001.11:11999029:C:G
NM_014874.4(MFN2):c.839G>A (p.Arg280His)	MFN2	R280H	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002271	1	12061480	1	12001423	2271	17310	rs28940294	NC_000001.11:12001422:G:A
NM_014874.4(MFN2):c.2219G>C (p.Trp740Ser)	MFN2	W740S	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Hereditary motor and sensory neuropathy with optic atrophy|not specified|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002269	1	12071567	1	12011510	2269	17308	rs28940292	NC_000001.11:12011509:G:C
NM_014874.4(MFN2):c.281G>A (p.Arg94Gln)	MFN2	R94Q	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002268	1	12052717	1	11992660	2268	17307	rs28940291	NC_000001.11:11992659:G:A
NM_001303256.3(MORC2):c.260C>T (p.Ser87Leu)	MORC2	S25L, S87L	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, type 2z|Global developmental delay	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000218308	22	31345795	22	30949809	218308	215004	rs864309504	NC_000022.11:30949808:G:A
NM_001303256.3(MORC2):c.754C>T (p.Arg252Trp)	MORC2	R252W	Inborn genetic diseases|Charcot-Marie-Tooth disease, axonal, type 2z|Charcot-Marie-Tooth disease|not provided|Distal spinal muscular atrophy	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000218307	22	31337490	22	30941503	218307	215003	rs864309503	NC_000022.11:30941502:G:A
NM_002437.5(MPV17):c.122G>A (p.Arg41Gln)	MPV17	R41Q	Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000626263	2	27535925	2	27313058	626263	614556	rs140992482	NC_000002.12:27313057:C:T
NM_002437.5(MPV17):c.293C>T (p.Pro98Leu)	MPV17	P98L	Charcot-Marie-Tooth disease, axonal, type 2EE|MPV17-Related Disorders|Navajo neurohepatopathy|not provided	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000038355	2	27535443	2	27312576	38355	46918	rs267607258	NC_000002.12:27312575:G:A
NM_000530.8(MPZ):c.171G>A (p.Trp57Ter)	MPZ	W57*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV001070662	1	161277111	1	161307321	1070662	1058461		NC_000001.11:161307320:C:T
NM_000530.8(MPZ):c.20C>G (p.Ser7Ter)	MPZ	S7*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000940939	1	161279676	1	161309886	940939	930123	rs1558155838	NC_000001.11:161309885:G:C
NM_000530.8(MPZ):c.235-1G>T	MPZ		not provided|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000935883	1	161276712	1	161306922	935883	939778	rs1571819375	NC_000001.11:161306921:C:A
NM_000530.8(MPZ):c.68-1G>A	MPZ		Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000655415	1	161277215	1	161307425	655415	650671	rs1057518021	NC_000001.11:161307424:C:T
NM_000530.8(MPZ):c.159G>A (p.Trp53Ter)	MPZ	W53*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000640717	1	161277123	1	161307333	640717	627028	rs1571820100	NC_000001.11:161307332:C:T
NM_000530.8(MPZ):c.194C>A (p.Thr65Asn)	MPZ	T65N	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jun 11, 2020)	criteria provided, single submitter	VCV000637928	1	161277088	1	161307298	637928	625072	rs1571819964	NC_000001.11:161307297:G:T
NM_000530.8(MPZ):c.316C>T (p.Arg106Cys)	MPZ	R106C	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV000637797	1	161276630	1	161306840	637797	625050	rs1571819084	NC_000001.11:161306839:G:A
NM_000530.8(MPZ):c.392A>G (p.Asn131Ser)	MPZ	N131S	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000637784	1	161276554	1	161306764	637784	625034	rs1571818819	NC_000001.11:161306763:T:C
NM_000530.8(MPZ):c.435T>A (p.Tyr145Ter)	MPZ	Y145*	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000637781	1	161276511	1	161306721	637781	625018	rs1571818632	NC_000001.11:161306720:A:T
NM_000530.8(MPZ):c.204C>A (p.Tyr68Ter)	MPZ	Y68*	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637508	1	161277078	1	161307288	637508	625066	rs1571819906	NC_000001.11:161307287:G:T
NM_000530.8(MPZ):c.197G>A (p.Trp66Ter)	MPZ	W66*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000637507	1	161277085	1	161307295	637507	625070	rs1571819946	NC_000001.11:161307294:C:T
NM_000530.8(MPZ):c.296T>C (p.Ile99Thr)	MPZ	I99T	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000637349	1	161276650	1	161306860	637349	625053	rs1571819182	NC_000001.11:161306859:A:G
NM_000530.8(MPZ):c.681A>T (p.Arg227Ser)	MPZ	R227S	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000637330	1	161275732	1	161305942	637330	624997	rs1571817146	NC_000001.11:161305941:T:A
NM_000530.8(MPZ):c.303G>A (p.Trp101Ter)	MPZ	W101*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000586153	1	161276643	1	161306853	586153	576434	rs1558154149	NC_000001.11:161306852:C:T
NM_000530.8(MPZ):c.411C>T (p.Gly137=)	MPZ		Charcot-Marie-Tooth disease, type I|Dejerine-Sottas disease	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000577671	1	161276535	1	161306745	577671	557010	rs1558153994	NC_000001.11:161306744:G:A
NM_000530.8(MPZ):c.302G>A (p.Trp101Ter)	MPZ	W101*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jul 13, 2019)	criteria provided, single submitter	VCV000570159	1	161276644	1	161306854	570159	556664	rs1017715903	NC_000001.11:161306853:C:T
NM_000530.8(MPZ):c.245A>G (p.Tyr82Cys)	MPZ	Y82C	Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549681	1	161276701	1	161306911	549681	540438	rs1553259707	NC_000001.11:161306910:T:C
NM_000530.8(MPZ):c.152C>T (p.Ser51Phe)	MPZ	S51F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000531693	1	161277130	1	161307340	531693	515335	rs1553259790	NC_000001.11:161307339:G:A
NM_000530.8(MPZ):c.298C>T (p.Gln100Ter)	MPZ	Q100*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000531678	1	161276648	1	161306858	531678	515242	rs1553259683	NC_000001.11:161306857:G:A
NM_000530.8(MPZ):c.397C>A (p.Pro133Thr)	MPZ	P133T	Roussy-Lévy syndrome|Charcot-Marie-Tooth disease dominant intermediate d|Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Congenital hypomyelinating neuropathy 1, autosomal recessive|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000462797	1	161276549	1	161306759	462797	447245	rs1553259648	NC_000001.11:161306758:G:T
NM_000530.8(MPZ):c.256C>T (p.Gln86Ter)	MPZ	Q86*	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000462792	1	161276690	1	161306900	462792	447368	rs1553259703	NC_000001.11:161306899:G:A
NM_000530.8(MPZ):c.103G>A (p.Asp35Asn)	MPZ	D35N	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000462790	1	161277179	1	161307389	462790	447442	rs121913596	NC_000001.11:161307388:C:T
NM_000530.8(MPZ):c.418T>A (p.Ser140Thr)	MPZ	S140T	not specified|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447730	1	161276528	1	161306738	447730	440403	rs572010627	NC_000001.11:161306737:A:T
NM_000530.8(MPZ):c.233C>G (p.Ser78Trp)	MPZ	S78W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000411669	1	161277049	1	161307259	411669	390849	rs121913601	NC_000001.11:161307258:G:C
NM_000530.8(MPZ):c.584+2T>G	MPZ		Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000246029	1	161276117	1	161306327	246029	244251	rs879254054	NC_000001.11:161306326:A:C
NM_000530.8(MPZ):c.356A>G (p.Tyr119Cys)	MPZ	Y119C	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000245997	1	161276590	1	161306800	245997	244253	rs879254038	NC_000001.11:161306799:T:C
NM_000530.8(MPZ):c.403A>C (p.Ile135Leu)	MPZ	I135L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243089	1	161276543	1	161306753	243089	244171	rs879253858	NC_000001.11:161306752:T:G
NM_000530.8(MPZ):c.106A>T (p.Arg36Trp)	MPZ	R36W	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: May 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000221065	1	161277176	1	161307386	221065	221083	rs864622732	NC_000001.11:161307385:T:A
NM_000530.8(MPZ):c.90C>G (p.Ile30Met)	MPZ	I30M	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217235	1	161277192	1	161307402	217235	213795	rs770546306	NC_000001.11:161307401:G:C
NM_000530.8(MPZ):c.116A>C (p.His39Pro)	MPZ	H39P	not specified|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: May 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217232	1	161277166	1	161307376	217232	213794	rs371856018	NC_000001.11:161307375:T:G
NM_000530.8(MPZ):c.499G>A (p.Gly167Arg)	MPZ	G167R	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000208149	1	161276204	1	161306414	208149	204407	rs121913586	NC_000001.11:161306413:C:T
NM_000530.8(MPZ):c.487G>A (p.Gly163Arg)	MPZ	G163R	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000208148	1	161276216	1	161306426	208148	204408	rs281865128	NC_000001.11:161306425:C:T
NM_000530.6(MPZ):c.[241C>T;337G>T]	MPZ	H81Y, V113F	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Mar 26, 2015)	no assertion criteria provided	VCV000208147	1|1	161276705	1|1	161306915	208147	49438|49442	rs281865123|rs281865126	NC_000001.11:161306914:G:A|NC_000001.11:161306818:C:A
NM_000530.8(MPZ):c.181G>A (p.Asp61Asn)	MPZ	D61N	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208146	1	161277101	1	161307311	208146	204409	rs797044845	NC_000001.11:161307310:C:T
NM_000530.8(MPZ):c.314C>T (p.Pro105Leu)	MPZ	P105L	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188325	1	161276632	1	161306842	188325	185951	rs786204215	NC_000001.11:161306841:G:A
NM_000530.8(MPZ):c.182A>G (p.Asp61Gly)	MPZ	D61G	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188168	1	161277100	1	161307310	188168	185952	rs786204119	NC_000001.11:161307309:T:C
NM_000530.8(MPZ):c.670G>T (p.Asp224Tyr)	MPZ	D224Y	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000041024	1	161275743	1	161305953	41024	49446	rs267607247	NC_000001.11:161305952:C:A
NM_000530.8(MPZ):c.487G>C (p.Gly163Arg)	MPZ	G163R	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000041022	1	161276216	1	161306426	41022	49444	rs281865128	NC_000001.11:161306425:C:G
NM_000530.8(MPZ):c.244T>C (p.Tyr82His)	MPZ	Y82H	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000041017	1	161276702	1	161306912	41017	49439	rs281865124	NC_000001.11:161306911:A:G
NM_000530.8(MPZ):c.178G>C (p.Asp60His)	MPZ	D60H	Charcot-Marie-Tooth disease type 2I	Pathogenic(Last reviewed: Jul 13, 2004)	no assertion criteria provided	VCV000014193	1	161277104	1	161307314	14193	29232	rs121913604	NC_000001.11:161307313:C:G
NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser)	MPZ	Y145S	not provided|Dejerine-Sottas disease|Roussy-Lévy syndrome|Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, demyelinating, type 1b|Congenital hypomyelinating neuropathy 1, autosomal recessive|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Nov 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014191	1	161276512	1	161306722	14191	29230	rs121913603	NC_000001.11:161306721:T:G
NM_000530.8(MPZ):c.233C>T (p.Ser78Leu)	MPZ	S78L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014188	1	161277049	1	161307259	14188	29227	rs121913601	NC_000001.11:161307258:G:A
NM_000530.8(MPZ):c.393C>A (p.Asn131Lys)	MPZ	N131K	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Roussy-Lévy syndrome|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014186	1	161276553	1	161306763	14186	29225	rs121913599	NC_000001.11:161306762:G:T
NM_000530.8(MPZ):c.131C>T (p.Ser44Phe)	MPZ	S44F	Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014185	1	161277151	1	161307361	14185	29224	rs121913598	NC_000001.11:161307360:G:A
NM_000530.8(MPZ):c.224A>T (p.Asp75Val)	MPZ	D75V	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease type 2J	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000014184	1	161277058	1	161307268	14184	29223	rs121913597	NC_000001.11:161307267:T:A
NM_000530.8(MPZ):c.103G>T (p.Asp35Tyr)	MPZ	D35Y	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease dominant intermediate d	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014183	1	161277179	1	161307389	14183	29222	rs121913596	NC_000001.11:161307388:C:A
NM_000530.6(MPZ):c.[266T>A;274G>A;486C>G]	MPZ	V92M, I162M, I89N	Charcot-Marie-Tooth disease type 2I	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000014182	1|1|1	161276672	1|1|1	161306882	14182	38404|38403|29221	rs267607245|rs267607246|rs267607244	NC_000001.11:161306881:C:T|NC_000001.11:161306426:G:C|NC_000001.11:161306889:A:T
NM_000530.8(MPZ):c.371C>T (p.Thr124Met)	MPZ	T124M	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|Roussy-Lévy syndrome|Congenital hypomyelinating neuropathy 1, autosomal recessive|Dejerine-Sottas disease|Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014181	1	161276575	1	161306785	14181	29220	rs121913595	NC_000001.11:161306784:G:A
NM_000530.6(MPZ):c.[341T>C;346A>C;382G>A]	MPZ	D128N, N116H, I114T	Dejerine-sottas syndrome, sporadic	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014180	1|1|1	161276564	1|1|1	161306774	14180	38402|38401|29219	rs267607243|rs267607242|rs267607241	NC_000001.11:161306773:C:T|NC_000001.11:161306809:T:G|NC_000001.11:161306814:A:G
NM_000530.8(MPZ):c.242A>G (p.His81Arg)	MPZ	H81R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014179	1	161276704	1	161306914	14179	29218	rs121913594	NC_000001.11:161306913:T:C
NM_000530.8(MPZ):c.188C>T (p.Ser63Phe)	MPZ	S63F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014177	1	161277094	1	161307304	14177	29216	rs121913585	NC_000001.11:161307303:G:A
NM_000530.8(MPZ):c.293G>A (p.Arg98His)	MPZ	R98H	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b|Distal muscle weakness|Pes cavus|Distal lower limb amyotrophy|Decreased nerve conduction velocity|Sensory neuropathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014176	1	161276653	1	161306863	14176	29215	rs121913589	NC_000001.11:161306862:C:T
NM_000530.8(MPZ):c.292C>T (p.Arg98Cys)	MPZ	R98C	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014175	1	161276654	1	161306864	14175	29214	rs121913590	NC_000001.11:161306863:G:A
NM_000530.8(MPZ):c.293G>C (p.Arg98Pro)	MPZ	R98P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b|none provided	Pathogenic(Last reviewed: Apr 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014174	1	161276653	1	161306863	14174	29213	rs121913589	NC_000001.11:161306862:C:G
NM_000530.8(MPZ):c.499G>C (p.Gly167Arg)	MPZ	G167R	Dejerine-Sottas disease|Roussy-Lévy syndrome|Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, demyelinating, type 1b|Congenital hypomyelinating neuropathy 1, autosomal recessive|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Dejerine-Sottas syndrome, autosomal dominant|Dejerine-Sottas disease	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	VCV000014170	1	161276204	1	161306414	14170	29209	rs121913586	NC_000001.11:161306413:C:G
NM_000530.8(MPZ):c.188C>G (p.Ser63Cys)	MPZ	S63C	Charcot-Marie-Tooth disease, type I|not provided|Dejerine-Sottas syndrome, autosomal dominant|Dejerine-Sottas disease	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014169	1	161277094	1	161307304	14169	29208	rs121913585	NC_000001.11:161307303:G:C
NM_000530.8(MPZ):c.270C>A (p.Asp90Glu)	MPZ	D90E	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014167	1	161276676	1	161306886	14167	29206	rs121913584	NC_000001.11:161306885:G:T
NM_000530.8(MPZ):c.286A>G (p.Lys96Glu)	MPZ	K96E	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000014166	1	161276660	1	161306870	14166	29205	rs121913583	NC_000001.11:161306869:T:C
NC_012920.1:m.8993T>C	MT-ATP6	L156P	Mitochondrial disease|Mitochondrial complex v (atp synthase) deficiency, mitochondrial type 1|NARP syndrome|Ataxia and polyneuropathy, adult-onset|Leigh syndrome|not provided	Pathogenic(Last reviewed: Feb 17, 2021)	reviewed by expert panel	VCV000009642	MT	8993	MT	8993	9642	24681	rs199476133	NC_012920.1:8992:T:C
NM_016156.6(MTMR2):c.1593+1G>A	MTMR2		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000637472	11	95571257	11	95838093	637472	625719	rs1590970875	NC_000011.10:95838092:C:T
NM_016156.6(MTMR2):c.1164G>A (p.Trp388Ter)	MTMR2	W388*, W316*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549685	11	95580893	11	95847729	549685	540457	rs1555060024	NC_000011.10:95847728:C:T
NM_016156.6(MTMR2):c.1444C>T (p.Gln482Ter)	MTMR2	Q482*, Q410*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006234	11	95574816	11	95841652	6234	21273	rs121434404	NC_000011.10:95841651:G:A
NM_016156.6(MTMR2):c.826G>T (p.Glu276Ter)	MTMR2	E276*, E204*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000006233	11	95583005	11	95849841	6233	21272	rs121434403	NC_000011.10:95849840:C:A
MTMR2, IVS13, G-A, +1	MTMR2		Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006232					6232	21271		
NM_016156.6(MTMR2):c.1276C>T (p.Gln426Ter)	MTMR2	Q426*, Q354*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000006231	11	95578227	11	95845063	6231	21270	rs121434402	NC_000011.10:95845062:G:A
NM_000263.4(NAGLU):c.603G>A (p.Trp201Ter)	NAGLU	W201*	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001076452	17	40690428	17	42538410	1076452	1064173		NC_000017.11:42538409:G:A
NM_000263.4(NAGLU):c.1162C>T (p.Gln388Ter)	NAGLU	Q388*	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: May 15, 2020)	criteria provided, single submitter	VCV001075574	17	40695186	17	42543168	1075574	1064174		NC_000017.11:42543167:C:T
NM_000263.4(NAGLU):c.432G>A (p.Trp144Ter)	NAGLU	W144*	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001071435	17	40689464	17	42537446	1071435	1064171		NC_000017.11:42537445:G:A
NM_000263.4(NAGLU):c.454C>T (p.Arg152Ter)	NAGLU	R152*	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001070682	17	40689486	17	42537468	1070682	1064172		NC_000017.11:42537467:C:T
NM_000263.4(NAGLU):c.1354G>A (p.Glu452Lys)	NAGLU	E452K	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000871076	17	40695378	17	42543360	871076	860385	rs1183634153	NC_000017.11:42543359:G:A
NM_000263.4(NAGLU):c.926A>G (p.Tyr309Cys)	NAGLU	Y309C	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV000841655	17	40693129	17	42541111	841655	845343	rs1305299665	NC_000017.11:42541110:A:G
NM_000263.4(NAGLU):c.1277G>A (p.Gly426Asp)	NAGLU	G426D	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000643204	17	40695301	17	42543283	643204	645903	rs771151036	NC_000017.11:42543282:G:A
NM_000263.4(NAGLU):c.1973A>G (p.Tyr658Cys)	NAGLU	Y658C	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV000572445	17	40695997	17	42543979	572445	574462	rs1230894568	NC_000017.11:42543978:A:G
NM_000263.4(NAGLU):c.1093C>T (p.Gln365Ter)	NAGLU	Q365*	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557513	17	40695117	17	42543099	557513	548453	rs1555622242	NC_000017.11:42543098:C:T
NM_000263.4(NAGLU):c.2020C>T (p.Arg674Cys)	NAGLU	R674C	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553061	17	40696044	17	42544026	553061	548939	rs763299645	NC_000017.11:42544025:C:T
NM_000263.4(NAGLU):c.1390C>T (p.Arg464Ter)	NAGLU	R464*	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552920	17	40695414	17	42543396	552920	548904	rs138387856	NC_000017.11:42543395:C:T
NM_000263.4(NAGLU):c.1241A>G (p.His414Arg)	NAGLU	H414R	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552833	17	40695265	17	42543247	552833	548470	rs768814260	NC_000017.11:42543246:A:G
NM_000263.4(NAGLU):c.358G>T (p.Glu120Ter)	NAGLU	E120*	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552642	17	40688648	17	42536630	552642	548425	rs1445294968	NC_000017.11:42536629:G:T
NM_000263.4(NAGLU):c.1211G>A (p.Trp404Ter)	NAGLU	W404*	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551331	17	40695235	17	42543217	551331	548454	rs904672363	NC_000017.11:42543216:G:A
NM_000263.4(NAGLU):c.1834A>G (p.Ser612Gly)	NAGLU	S612G	Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522823	17	40695858	17	42543840	522823	513465	rs148881970	NC_000017.11:42543839:A:G
NM_000263.4(NAGLU):c.1597C>T (p.Arg533Ter)	NAGLU	R533*	Mucopolysaccharidosis, MPS-III-B|not provided|Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495784	17	40695621	17	42543603	495784	487839	rs1244655820	NC_000017.11:42543602:C:T
NM_000263.4(NAGLU):c.419A>G (p.Tyr140Cys)	NAGLU	Y140C	Hypertrichosis|Abnormality of metabolism/homeostasis|Coarse facial features|Abnormal facial shape|Thick eyebrow|Hepatosplenomegaly|Mucopolysacchariduria|Intellectual disability, severe|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371634	17	40689451	17	42537433	371634	358436	rs753520553	NC_000017.11:42537432:A:G
NM_000263.4(NAGLU):c.694C>T (p.Gln232Ter)	NAGLU	Q232*	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000288040	17	40690703	17	42538685	288040	272277	rs886043792	NC_000017.11:42538684:C:T
NM_000263.4(NAGLU):c.367G>T (p.Glu123Ter)	NAGLU	E123*	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|not provided	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV000204586	17	40688657	17	42536639	204586	200976	rs796052123	NC_000017.11:42536638:G:T
NM_000263.4(NAGLU):c.1949G>A (p.Gly650Glu)	NAGLU	G650E	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143188	17	40695973	17	42543955	143188	152906	rs527236037	NC_000017.11:42543954:G:A
NM_000263.4(NAGLU):c.1694G>A (p.Arg565Gln)	NAGLU	R565Q	Sanfilippo syndrome|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030795	17	40695718	17	42543700	30795	39752	rs104894598	NC_000017.11:42543699:G:A
NM_000263.4(NAGLU):c.700C>T (p.Arg234Cys)	NAGLU	R234C	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001572	17	40690709	17	42538691	1572	16611	rs104894601	NC_000017.11:42538690:C:T
NM_000263.4(NAGLU):c.1444C>T (p.Arg482Trp)	NAGLU	R482W	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001571	17	40695468	17	42543450	1571	16610	rs104894596	NC_000017.11:42543449:C:T
NM_000263.4(NAGLU):c.1693C>T (p.Arg565Trp)	NAGLU	R565W	Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001567	17	40695717	17	42543699	1567	16606	rs104894597	NC_000017.11:42543698:C:T
NM_000263.4(NAGLU):c.1562C>T (p.Pro521Leu)	NAGLU	P521L	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001566	17	40695586	17	42543568	1566	16605	rs104894595	NC_000017.11:42543567:C:T
NM_000263.4(NAGLU):c.1927C>T (p.Arg643Cys)	NAGLU	R643C	Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000001565	17	40695951	17	42543933	1565	16604	rs104894594	NC_000017.11:42543932:C:T
NM_000263.4(NAGLU):c.889C>T (p.Arg297Ter)	NAGLU	R297*	Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001562	17	40693092	17	42541074	1562	16601	rs104894592	NC_000017.11:42541073:C:T
NM_000263.4(NAGLU):c.1876C>T (p.Arg626Ter)	NAGLU	R626*	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001561	17	40695900	17	42543882	1561	16600	rs104894591	NC_000017.11:42543881:C:T
NM_000263.4(NAGLU):c.2021G>A (p.Arg674His)	NAGLU	R674H	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001560	17	40696045	17	42544027	1560	16599	rs104894590	NC_000017.11:42544026:G:A
NM_006158.5(NEFL):c.18C>G (p.Tyr6Ter)	NEFL	Y6*	Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, single submitter	VCV001333320	8	24814012	8	24956498	1333320	1324095		NC_000008.11:24956497:G:C
NM_006158.5(NEFL):c.1099C>T (p.Arg367Ter)	NEFL	R367*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001074146	8	24811765	8	24954251	1074146	1061293		NC_000008.11:24954250:G:A
NM_006158.5(NEFL):c.32C>A (p.Ser11Ter)	NEFL	S11*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000852797	8	24813998	8	24956484	852797	834566	rs766951637	NC_000008.11:24956483:G:T
NM_006158.5(NEFL):c.1117C>T (p.Gln373Ter)	NEFL	Q373*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000533513	8	24811747	8	24954233	533513	523411	rs757417962	NC_000008.11:24954232:G:A
NM_006158.5(NEFL):c.487G>T (p.Glu163Ter)	NEFL	E163*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000369981	8	24813543	8	24956029	369981	354198	rs876661155	NC_000008.11:24956028:C:A
NM_006158.5(NEFL):c.1179G>C (p.Leu393Phe)	NEFL	L393F	not provided|Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000245748	8	24811300	8	24953786	245748	244521	rs879253927	NC_000008.11:24953785:C:G
NM_006158.5(NEFL):c.1261C>T (p.Arg421Ter)	NEFL	R421*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2E	Pathogenic	criteria provided, single submitter	VCV000192322	8	24811218	8	24953704	192322	190114	rs191346286	NC_000008.11:24953703:G:A
NM_006158.5(NEFL):c.1319C>T (p.Pro440Leu)	NEFL	P440L	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000155738	8	24811160	8	24953646	155738	165492	rs587777882	NC_000008.11:24953645:G:A
NM_006158.5(NEFL):c.23C>T (p.Pro8Leu)	NEFL	P8L	not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000066689	8	24814007	8	24956493	66689	77586	rs61491953	NC_000008.11:24956492:G:A
NM_006158.5(NEFL):c.23C>G (p.Pro8Arg)	NEFL	P8R	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000066688	8	24814007	8	24956493	66688	77585	rs61491953	NC_000008.11:24956492:G:C
NM_006158.5(NEFL):c.23C>A (p.Pro8Gln)	NEFL	P8Q	Charcot-Marie-Tooth disease|not provided	Pathogenic	criteria provided, single submitter	VCV000066687	8	24814007	8	24956493	66687	77584	rs61491953	NC_000008.11:24956492:G:T
NM_006158.5(NEFL):c.1186G>A (p.Glu396Lys)	NEFL	E396K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate G|not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000066671	8	24811293	8	24953779	66671	77568	rs62636503	NC_000008.11:24953778:C:T
NM_006158.5(NEFL):c.293A>G (p.Asn98Ser)	NEFL	N98S	Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease, dominant intermediate G|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, dominant intermediate G|Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000041236	8	24813737	8	24956223	41236	49660	rs58982919	NC_000008.11:24956222:T:C
NM_006158.5(NEFL):c.628G>T (p.Glu210Ter)	NEFL	E210*	Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000029803	8	24813402	8	24955888	29803	38758	rs199422214	NC_000008.11:24955887:C:A
NM_006158.5(NEFL):c.418G>T (p.Glu140Ter)	NEFL	E140*	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000014034	8	24813612	8	24956098	14034	29073	rs121913663	NC_000008.11:24956097:C:A
NM_006158.5(NEFL):c.281T>C (p.Leu94Pro)	NEFL	L94P	not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000014033	8	24813749	8	24956235	14033	29072	rs62636505	NC_000008.11:24956234:A:G
NM_006158.5(NEFL):c.64C>T (p.Pro22Ser)	NEFL	P22S	Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, demyelinating, type 1f|Pes cavus|Distal lower limb muscle weakness|Peripheral neuropathy|Peripheral demyelination|Decreased nerve conduction velocity|Hand muscle atrophy|Peripheral neuropathy|Distal muscle weakness|Charcot-Marie-Tooth disease, type 1C|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014029	8	24813966	8	24956452	14029	29068	rs28928910	NC_000008.11:24956451:G:A
NM_006158.5(NEFL):c.995A>C (p.Gln332Pro)	NEFL	Q332P	not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000014028	8	24813035	8	24955521	14028	29067	rs59443585	NC_000008.11:24955520:T:G
NM_002529.4(NTRK1):c.2303C>T (p.Pro768Leu)	NTRK1	P768L, P732L, P762L	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000637485	1	156851346	1	156881554	637485	624990	rs756981419	NC_000001.11:156881553:C:T
NM_002529.4(NTRK1):c.429-1G>C	NTRK1		Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000637475	1	156837895	1	156868103	637475	625729	rs748672380	NC_000001.11:156868102:G:C
NM_002529.4(NTRK1):c.1960C>T (p.Arg654Cys)	NTRK1	R618C, R648C, R654C	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV000637430	1	156849068	1	156879276	637430	624987	rs764992664	NC_000001.11:156879275:C:T
NM_002529.4(NTRK1):c.574+1G>A	NTRK1		Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000637365	1	156838042	1	156868250	637365	625730	rs1232901259	NC_000001.11:156868249:G:A
NM_002529.4(NTRK1):c.1804C>T (p.Arg602Ter)	NTRK1	R566*, R596*, R602*	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis|not provided	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620139	1	156846363	1	156876571	620139	611494	rs763758904	NC_000001.11:156876570:C:T
NM_002529.4(NTRK1):c.638T>C (p.Leu213Pro)	NTRK1	L183P, L213P	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV000526734	1	156838360	1	156868568	526734	515140	rs747711259	NC_000001.11:156868567:T:C
NM_000304.4(PMP22):c.236C>T (p.Ser79Phe)	PMP22	S79F	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001072721	17	15142871	17	15239554	1072721	1063846		NC_000017.11:15239553:G:A
NM_000304.4(PMP22):c.351C>A (p.Tyr117Ter)	PMP22	Y117*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000846662	17	15134366	17	15231049	846662	844719	rs1906290133	NC_000017.11:15231048:G:T
NM_000304.4(PMP22):c.420G>A (p.Trp140Ter)	PMP22	W140*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000648604	17	15134297	17	15230980	648604	645317	rs1597597527	NC_000017.11:15230979:C:T
NM_000304.4(PMP22):c.179-2A>G	PMP22		Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000637829	17	15142930	17	15239613	637829	625765	rs1597608225	NC_000017.11:15239612:T:C
NM_000304.4(PMP22):c.256C>T (p.Gln86Ter)	PMP22	Q86*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000637389	17	15142851	17	15239534	637389	625386	rs11545341	NC_000017.11:15239533:G:A
NM_000304.4(PMP22):c.320G>T (p.Gly107Val)	PMP22	G107V	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000637376	17	15134397	17	15231080	637376	625377	rs1597597900	NC_000017.11:15231079:C:A
NM_000304.4(PMP22):c.79-2A>G	PMP22		not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000637371	17	15162512	17	15259195	637371	625768	rs1597633171	NC_000017.11:15259194:T:C
NM_000304.4(PMP22):c.307C>T (p.Gln103Ter)	PMP22	Q103*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000618333	17	15142800	17	15239483	618333	610055	rs1567704621	NC_000017.11:15239482:G:A
NM_000304.4(PMP22):c.83G>A (p.Trp28Ter)	PMP22	W28*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000531680	17	15162506	17	15259189	531680	531103	rs1555568475	NC_000017.11:15259188:C:T
NM_000304.4(PMP22):c.449G>T (p.Gly150Val)	PMP22	G150V	Charcot-Marie-Tooth disease and deafness|Dejerine-Sottas disease	Pathogenic	no assertion criteria provided	VCV000433198	17	15134268	17	15230951	433198	426772	rs879253954	NC_000017.11:15230950:C:A
NM_000304.4(PMP22):c.448G>C (p.Gly150Arg)	PMP22	G150R	Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000384327	17	15134269	17	15230952	384327	375772	rs104894624	NC_000017.11:15230951:C:G
NM_000304.4(PMP22):c.449G>A (p.Gly150Asp)	PMP22	G150D	Charcot-Marie-Tooth disease, type I|not provided|Dejerine-Sottas disease	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245805	17	15134268	17	15230951	245805	245013	rs879253954	NC_000017.11:15230950:C:T
NM_000304.4(PMP22):c.327C>A (p.Cys109Ter)	PMP22	C109*	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217237	17	15134390	17	15231073	217237	213836	rs863225028	NC_000017.11:15231072:G:T
NM_000304.4(PMP22):c.82T>C (p.Trp28Arg)	PMP22	W28R	Charcot-Marie-Tooth disease and deafness	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000008440	17	15162507	17	15259190	8440	23479	rs104894626	NC_000017.11:15259189:A:G
NM_000304.4(PMP22):c.199G>C (p.Ala67Pro)	PMP22	A67P	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease and deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008436	17	15142908	17	15239591	8436	23475	rs104894623	NC_000017.11:15239590:C:G
NM_000304.4(PMP22):c.36C>A (p.His12Gln)	PMP22	H12Q	Inborn genetic diseases|Charcot-Marie-Tooth disease, type I|Dejerine-Sottas disease|Dejerine-Sottas syndrome, autosomal dominant|Roussy-Lévy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008434	17	15164009	17	15260692	8434	23473	rs104894622	NC_000017.11:15260691:G:T
NM_000304.4(PMP22):c.215C>T (p.Ser72Leu)	PMP22	S72L	Inborn genetic diseases|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, type IA|Dejerine-Sottas syndrome, autosomal dominant	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008433	17	15142892	17	15239575	8433	23472	rs104894621	NC_000017.11:15239574:G:A
NM_000304.4(PMP22):c.206T>A (p.Met69Lys)	PMP22	M69K	Charcot-Marie-Tooth disease, type I|not provided|Dejerine-Sottas syndrome, autosomal dominant	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008432	17	15142901	17	15239584	8432	23471	rs104894620	NC_000017.11:15239583:A:T
NM_000304.4(PMP22):c.47T>C (p.Leu16Pro)	PMP22	L16P	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, type IA	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000008428	17	15163998	17	15260681	8428	23467	rs104894617	NC_000017.11:15260680:A:G
NM_002693.3(POLG):c.2209G>C (p.Gly737Arg)	POLG	G737R	Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive sclerosing poliodystrophy|Mitochondrial disease|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|none provided|Seizures|POLG-Related Spectrum Disorders	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013513	15	89866691	15	89323460	13513	28552	rs121918054	NC_000015.10:89323459:C:G
NM_002764.4(PRPS1):c.46T>C (p.Ser16Pro)	PRPS1	S16P	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000223101	X	106871904	X	107628674	223101	224828	rs869025594	NC_000023.11:107628673:T:C
NM_002764.4(PRPS1):c.925G>T (p.Val309Phe)	PRPS1	V105F	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000140573	X	106893230	X	107650000	140573	150247	rs587781263	NC_000023.11:107649999:G:T
NM_002764.4(PRPS1):c.343A>G (p.Met115Val)	PRPS1		Deafness, X-linked 1|Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000140572	X	106884168	X	107640938	140572	150246	rs587781262	NC_000023.11:107640937:A:G
NM_002764.4(PRPS1):c.362C>G (p.Ala121Gly)	PRPS1	A121G	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000100767	X	106884187	X	107640957	100767	106633	rs587777150	NC_000023.11:107640956:C:G
NM_002764.4(PRPS1):c.129A>C (p.Glu43Asp)	PRPS1	E43D	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Aug 26, 2008)	no assertion criteria provided	VCV000009934	X	106882531	X	107639301	9934	24973	rs80338731	NC_000023.11:107639300:A:C
NM_181882.3(PRX):c.2689C>T (p.Arg897Ter)	PRX	R897*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000646421	19	40901570	19	40395663	646421	648104	rs756689732	NC_000019.10:40395662:G:A
NM_181882.3(PRX):c.1864C>T (p.Gln622Ter)	PRX	Q622*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided	Pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000637509	19	40902395	19	40396488	637509	625424	rs1210729449	NC_000019.10:40396487:G:A
NM_181882.3(PRX):c.2145T>A (p.Cys715Ter)	PRX	C715*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic/Likely pathogenic(Last reviewed: Aug 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004792	19	40902114	19	40396207	4792	19831	rs104894707	NC_000019.10:40396206:A:T
NM_181882.3(PRX):c.586C>T (p.Arg196Ter)	PRX	R196*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000004791	19	40903673	19	40397766	4791	19830	rs104894706	NC_000019.10:40397765:G:A
NM_181882.3(PRX):c.1102C>T (p.Arg368Ter)	PRX	R368*	Charcot-Marie-Tooth disease type 4|Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004789	19	40903157	19	40397250	4789	19828	rs104894715	NC_000019.10:40397249:G:A
NM_181882.3(PRX):c.2857C>T (p.Arg953Ter)	PRX	R953*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided|Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004787	19	40901402	19	40395495	4787	19826	rs104894714	NC_000019.10:40395494:G:A
NM_004208.4(AIFM1):c.784G>A (p.Gly262Ser)	RAB33A|AIFM1	G262S, G258S	Cowchock syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000732670	X	129273844	X	130139869	732670	745480	rs1603224817	NC_000023.11:130139868:C:T
NM_004637.6(RAB7A):c.471G>T (p.Lys157Asn)	RAB7A	K157N	Charcot-Marie-Tooth disease type 2B	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000846631	3	128526457	3	128807614	846631	827519	rs121909081	NC_000003.12:128807613:G:T
NM_004637.6(RAB7A):c.482A>T (p.Asn161Ile)	RAB7A	N161I	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2B	Pathogenic(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV000637404	3	128526468	3	128807625	637404	625104	rs121909080	NC_000003.12:128807624:A:T
NM_004637.6(RAB7A):c.484G>A (p.Val162Met)	RAB7A	V162M	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2B	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV000007346	3	128526470	3	128807627	7346	22385	rs121909079	NC_000003.12:128807626:G:A
NM_004637.6(RAB7A):c.385C>T (p.Leu129Phe)	RAB7A	L129F	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 2B	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV000007345	3	128525419	3	128806576	7345	22384	rs121909078	NC_000003.12:128806575:C:T
NM_001034850.3(RETREG1):c.433C>T (p.Gln145Ter)	RETREG1	Q145*	Hereditary sensory and autonomic neuropathy type IIB|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000000330	5	16565897	5	16565788	330	15369	rs137852737	NC_000005.10:16565787:G:A
NM_001034850.3(RETREG1):c.926C>G (p.Ser309Ter)	RETREG1	S309*, S168*	not provided|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type IIB	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000328	5	16477845	5	16477736	328	15367	rs137852739	NC_000005.10:16477735:G:C
NM_030962.4(SBF2):c.1459C>T (p.Arg487Ter)	SBF2	R487*, R444*	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000002912	11	9990029	11	9968482	2912	17951	rs120074139	NC_000011.10:9968481:G:A
NM_015046.5(SETX):c.[3880C>T;822G>H]	SETX	R1294C, M274I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: May 23, 2006)	no assertion criteria provided	VCV000441281	9|9	135203105	9|9	132327718	441281	38425|17333	rs267607044|rs997473183	NC_000009.12:132327717:G:A|NC_000009.12:132334623:C:D
NM_024577.4(SH3TC2):c.2095C>T (p.Gln699Ter)	SH3TC2	Q699*	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000916841	5	148407200	5	149027637	916841	905152	rs1754094644	NC_000005.10:149027636:G:A
NM_024577.4(SH3TC2):c.1378C>T (p.Gln460Ter)	SH3TC2	Q460*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000637510	5	148407917	5	149028354	637510	625125	rs1580901350	NC_000005.10:149028353:G:A
NM_024577.4(SH3TC2):c.3596G>A (p.Trp1199Ter)	SH3TC2	W1199*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000579413	5	148386523	5	149006960	579413	560193	rs761972717	NC_000005.10:149006959:C:T
NM_024577.4(SH3TC2):c.3511C>T (p.Arg1171Cys)	SH3TC2	R1171C	Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease, type 4C|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000448370	5	148386608	5	149007045	448370	440868	rs759785462	NC_000005.10:149007044:G:A
NM_024577.4(SH3TC2):c.2642A>G (p.Asn881Ser)	SH3TC2	N881S	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type 4C	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377021	5	148406653	5	149027090	377021	363899	rs80338930	NC_000005.10:149027089:T:C
NM_024577.4(SH3TC2):c.3154C>T (p.Arg1052Ter)	SH3TC2	R1052*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220408	5	148392197	5	149012634	220408	221609	rs370115218	NC_000005.10:149012633:G:A
NM_024577.4(SH3TC2):c.279G>A (p.Lys93=)	SH3TC2		not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV000216120	5	148427425	5	149047862	216120	212513	rs776221160	NC_000005.10:149047861:C:T
NM_024577.4(SH3TC2):c.1972C>T (p.Arg658Cys)	SH3TC2	R658C	Charcot-Marie-Tooth disease, type 4C|Mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000021690	5	148407323	5	149027760	21690	34542	rs80338926	NC_000005.10:149027759:G:A
NM_024577.4(SH3TC2):c.1969G>A (p.Glu657Lys)	SH3TC2	E657K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000021689	5	148407326	5	149027763	21689	34541	rs80338925	NC_000005.10:149027762:C:T
NM_024577.4(SH3TC2):c.1178-1G>A	SH3TC2		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000021688	5	148408118	5	149028555	21688	34540	rs80338922	NC_000005.10:149028554:C:T
NM_024577.4(SH3TC2):c.3325C>T (p.Arg1109Ter)	SH3TC2	R1109*	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Sep 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002483	5	148389835	5	149010272	2483	17522	rs80338934	NC_000005.10:149010271:G:A
NM_024577.4(SH3TC2):c.2860C>T (p.Arg954Ter)	SH3TC2	R954*	not provided|none provided|Charcot-Marie-Tooth disease, type 4C|Inborn genetic diseases|Charcot-Marie-Tooth disease, type 4C|Mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4|Mononeuropathy of the median nerve, mild|SH3TC2-Related Disorders|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002482	5	148406435	5	149026872	2482	17521	rs80338933	NC_000005.10:149026871:G:A
NM_001365088.1(SLC12A6):c.1118+1G>A	SLC12A6		Charcot-Marie-Tooth disease|not provided|Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370139	15	34546548	15	34254347	370139	358288	rs762730861	NC_000015.10:34254346:C:T
NM_025137.4(SPG11):c.1085G>A (p.Trp362Ter)	SPG11	W362*	Spastic paraplegia 11, autosomal recessive|not provided|Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X	Pathogenic(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488833	15	44944060	15	44651862	488833	482070	rs140385286	NC_000015.10:44651861:C:T
NM_025137.4(SPG11):c.1621C>T (p.Gln541Ter)	SPG11	Q541*	Charcot-Marie-Tooth disease, axonal type 2X|not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Mar 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000235891	15	44925817	15	44633619	235891	237526	rs765061840	NC_000015.10:44633618:G:A
NM_025137.4(SPG11):c.6899T>C (p.Leu2300Pro)	SPG11	L2300P, L2187P	Charcot-Marie-Tooth disease, axonal type 2X|not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000235890	15	44858152	15	44565954	235890	237525	rs371334506	NC_000015.10:44565953:A:G
NM_025137.4(SPG11):c.592C>T (p.Gln198Ter)	SPG11	Q198*	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000218143	15	44951352	15	44659154	218143	214791	rs863225440	NC_000015.10:44659153:G:A
NM_025137.4(SPG11):c.3291+1G>T	SPG11		Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000041304	15	44903037	15	44610839	41304	49728	rs312262753	NC_000015.10:44610838:C:A
NM_025137.4(SPG11):c.2833A>G (p.Arg945Gly)	SPG11	R945G	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000041298	15	44912389	15	44620191	41298	49722	rs312262748	NC_000015.10:44620190:T:C
NM_025137.4(SPG11):c.2146C>T (p.Gln716Ter)	SPG11	Q716*	Charcot-Marie-Tooth disease, axonal type 2X|not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000041285	15	44918627	15	44626429	41285	49709	rs312262737	NC_000015.10:44626428:G:A
NM_025137.4(SPG11):c.118C>T (p.Gln40Ter)	SPG11	Q40*	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|not provided|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000001111	15	44955728	15	44663530	1111	16150	rs267607084	NC_000015.10:44663529:G:A
NM_025137.4(SPG11):c.6100C>T (p.Arg2034Ter)	SPG11	R2034*	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001109	15	44865850	15	44573652	1109	16148	rs118203963	NC_000015.10:44573651:G:A
NM_006415.4(SPTLC1):c.992C>A (p.Ser331Tyr)	SPTLC1	S331Y, S176Y, S209Y	Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type IA, severe|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372788	9	94809543	9	92047261	372788	359759	rs267607087	NC_000009.12:92047260:G:T
NM_006415.4(SPTLC1):c.399T>G (p.Cys133Trp)	SPTLC1	C133W	Sensorimotor neuropathy|Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type 1A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004803	9	94842326	9	92080044	4803	19842	rs119482082	NC_000009.12:92080043:A:C
NM_006415.4(SPTLC1):c.431T>A (p.Val144Asp)	SPTLC1	V144D, V22D	not provided|Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|Neuropathy, hereditary sensory and autonomic, type 1A	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004801	9	94830377	9	92068095	4801	19840	rs119482083	NC_000009.12:92068094:A:T
NM_006415.4(SPTLC1):c.398G>A (p.Cys133Tyr)	SPTLC1	C133Y	Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type 1A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000004800	9	94842327	9	92080045	4800	19839	rs119482081	NC_000009.12:92080044:C:T
NM_004863.4(SPTLC2):c.1151C>T (p.Ser384Phe)	SPTLC2	S384F	Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type IC|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000637418	14	78021668	14	77555325	637418	625308	rs1594986869	NC_000014.9:77555324:G:A
NM_003172.4(SURF1):c.586C>T (p.Gln196Ter)	SURF1	Q196*, Q87*	Leigh syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000243077	9	136219551	9	133352696	243077	244160	rs147816470	NC_000009.12:133352695:G:A
NM_003172.4(SURF1):c.574C>T (p.Arg192Trp)	SURF1	R192W, R83W	not provided|Charcot-Marie-Tooth disease, type 4k|Leigh syndrome	Pathogenic(Last reviewed: Mar 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000215235	9	136219563	9	133352708	215235	211361	rs782190413	NC_000009.12:133352707:G:A
NM_021625.5(TRPV4):c.709C>G (p.Arg237Gly)	TRPV4	R203G, R237G	Charcot-Marie-Tooth disease axonal type 2C	Pathogenic(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001073853	12	110240799	12	109802994	1073853	1062574		NC_000012.12:109802993:G:C
NM_021625.5(TRPV4):c.943C>G (p.Arg315Gly)	TRPV4	R315G, R268G, R281G	Charcot-Marie-Tooth disease axonal type 2C	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000858193	12	110236628	12	109798823	858193	839281	rs267607143	NC_000012.12:109798822:G:C
NM_021625.4(TRPV4):c.[2481_2484delCCGC;2486T>A]	TRPV4	R781fs, R828fs, R721fs, R768fs, R794fs, V829E, V795E, V722E, V782E, V769E	Avascular necrosis of femoral head, primary, 2	Pathogenic(Last reviewed: Mar 3, 2017)	no assertion criteria provided	VCV000378057	12|12	110221558 - 110221561	12|12	109783753 - 109783756	378057	380146|472257	rs1057520305|rs1555204446	NC_000012.12:109783752:GCGGG:G|NC_000012.12:109783750:A:T
NM_021625.5(TRPV4):c.819C>G (p.Phe273Leu)	TRPV4	F273L, F239L	Digital arthropathy-brachydactyly, familial	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000126483	12	110238457	12	109800652	126483	132010	rs515726170	NC_000012.12:109800651:G:C
NM_021625.5(TRPV4):c.1853T>C (p.Leu618Pro)	TRPV4	L584P, L558P, L571P, L511P	not provided|Metatrophic dysplasia|Skeletal dysplasia	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000126473	12	110230206	12	109792401	126473	132000	rs515726163	NC_000012.12:109792400:A:G
NM_021625.5(TRPV4):c.1219A>G (p.Lys407Glu)	TRPV4	K373E, K360E	Metatrophic dysplasia|Skeletal dysplasia	Pathogenic	criteria provided, single submitter	VCV000126463	12	110234443	12	109796638	126463	131990	rs515726153	NC_000012.12:109796637:T:C
NM_021625.5(TRPV4):c.557G>A (p.Arg186Gln)	TRPV4	R186Q, R152Q	not provided|Inborn genetic diseases|Distal spinal muscular atrophy, congenital nonprogressive|Charcot-Marie-Tooth disease axonal type 2C|Neuromuscular disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039419	12	110246103	12	109808298	39419	48018	rs397514494	NC_000012.12:109808297:C:T
NM_021625.5(TRPV4):c.809G>T (p.Gly270Val)	TRPV4	G270V, G236V	Digital arthropathy-brachydactyly, familial	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000035513	12	110238467	12	109800662	35513	44190	rs387907220	NC_000012.12:109800661:C:A
NM_021625.5(TRPV4):c.812G>C (p.Arg271Pro)	TRPV4	R271P, R237P	Digital arthropathy-brachydactyly, familial	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000035512	12	110238464	12	109800659	35512	44189	rs387907219	NC_000012.12:109800658:C:G
NM_021625.5(TRPV4):c.826A>G (p.Lys276Glu)	TRPV4	K276E, K242E	Metatrophic dysplasia|Neuromuscular disease|Skeletal dysplasia|not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000030476	12	110238450	12	109800645	30476	39433	rs387906907	NC_000012.12:109800644:T:C
NM_021625.5(TRPV4):c.2219C>T (p.Thr740Ile)	TRPV4	T706I, T693I, T633I, T680I	Metatrophic dysplasia|Neuromuscular disease|Skeletal dysplasia	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000030475	12	110224632	12	109786827	30475	39432	rs387906906	NC_000012.12:109786826:G:A
NM_021625.5(TRPV4):c.232G>T (p.Gly78Trp)	TRPV4	G78W, G44W	Metatrophic dysplasia|Neuromuscular disease|Skeletal dysplasia	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000030474	12	110252370	12	109814565	30474	39431	rs397514474	NC_000012.12:109814564:C:A
NM_021625.5(TRPV4):c.947G>A (p.Arg316His)	TRPV4	R316H, R269H, R282H	not provided|EMG abnormality|Lower limb amyotrophy|Clubfoot|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2C|Neuromuscular disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030473	12	110236624	12	109798819	30473	39430	rs387906905	NC_000012.12:109798818:C:T
NM_021625.5(TRPV4):c.694C>T (p.Arg232Cys)	TRPV4	R232C, R198C	Autosomal dominant distal hereditary motor neuropathy|Spondylometaphyseal dysplasia, Kozlowski type|Charcot-Marie-Tooth disease|Distal spinal muscular atrophy, congenital nonprogressive|not provided|Charcot-Marie-Tooth disease axonal type 2C|Neuromuscular disease|Skeletal dysplasia	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030472	12	110240814	12	109803009	30472	39429	rs387906904	NC_000012.12:109803008:G:A
NM_021625.5(TRPV4):c.266C>T (p.Thr89Ile)	TRPV4	T89I, T55I	Skeletal dysplasia|Metatrophic dysplasia	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000030470	12	110252336	12	109814531	30470	39427	rs397514473	NC_000012.12:109814530:G:A
NM_021625.5(TRPV4):c.1625C>A (p.Ser542Tyr)	TRPV4	S435Y, S482Y, S495Y, S508Y	Charcot-Marie-Tooth disease axonal type 2C|Neuromuscular disease|Skeletal dysplasia	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000030469	12	110231365	12	109793560	30469	39426	rs387906902	NC_000012.12:109793559:G:T
NM_021625.5(TRPV4):c.1805A>G (p.Tyr602Cys)	TRPV4	Y495C, Y542C, Y555C, Y568C	Skeletal dysplasia|Spondyloepiphyseal dysplasia Maroteaux type	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000030468	12	110230476	12	109792671	30468	39425	rs267607150	NC_000012.12:109792670:T:C
NM_021625.5(TRPV4):c.547G>A (p.Glu183Lys)	TRPV4	E183K, E149K	Skeletal dysplasia|Spondyloepiphyseal dysplasia Maroteaux type	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000018437	12	110246113	12	109808308	18437	33476	rs387906324	NC_000012.12:109808307:C:T
NM_021625.5(TRPV4):c.2389G>A (p.Glu797Lys)	TRPV4	E690K, E750K, E763K, E737K	Neuromuscular disease|Skeletal dysplasia|not provided|Metatrophic dysplasia|Spondylometaphyseal dysplasia, Kozlowski type|Brachyrachia (short spine dysplasia)|Spondyloepiphyseal dysplasia Maroteaux type	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018435	12	110222190	12	109784385	18435	33474	rs267607149	NC_000012.12:109784384:C:T
NM_021625.5(TRPV4):c.2396C>G (p.Pro799Arg)	TRPV4	P752R, P692R, P739R, P765R	Neuromuscular disease|Skeletal dysplasia|Metatrophic dysplasia	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000018432	12	110222183	12	109784378	18432	33471	rs121912637	NC_000012.12:109784377:G:C
NM_021625.5(TRPV4):c.2395C>T (p.Pro799Ser)	TRPV4	P739S, P765S, P692S, P752S	Skeletal dysplasia|Metatrophic dysplasia	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000018431	12	110222184	12	109784379	18431	33470	rs267607147	NC_000012.12:109784378:G:A
NM_021625.5(TRPV4):c.2395C>G (p.Pro799Ala)	TRPV4	P799A, P692A, P739A, P752A, P765A	Metatrophic dysplasia	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000018430	12	110222184	12	109784379	18430	33469	rs267607147	NC_000012.12:109784378:G:C
NM_021625.5(TRPV4):c.805C>T (p.Arg269Cys)	TRPV4	R269C, R235C	Hereditary motor neuron disease|Neuromuscular disease|not provided|Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease axonal type 2C|Distal spinal muscular atrophy, congenital nonprogressive|Distal spinal muscular atrophy	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005002	12	110238471	12	109800666	5002	20041	rs267607146	NC_000012.12:109800665:G:A
NM_021625.5(TRPV4):c.946C>T (p.Arg316Cys)	TRPV4	R316C, R282C, R269C	Autosomal dominant distal hereditary motor neuropathy|Neuromuscular disease|not provided|Charcot-Marie-Tooth disease|TRPV4-related disorders|Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease axonal type 2C	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005001	12	110236625	12	109798820	5001	20040	rs267607145	NC_000012.12:109798819:G:A
NM_021625.5(TRPV4):c.806G>A (p.Arg269His)	TRPV4	R269H, R235H	Charcot-Marie-Tooth disease axonal type 2C|Brachyrachia (short spine dysplasia)|Distal spinal muscular atrophy, congenital nonprogressive|Spondyloepiphyseal dysplasia Maroteaux type|Spondylometaphyseal dysplasia, Kozlowski type|Metatrophic dysplasia|Scapuloperoneal spinal muscular atrophy|Avascular necrosis of femoral head, primary, 2|Charcot-Marie-Tooth disease axonal type 2C|Sodium serum level quantitative trait locus 1|Parastremmatic dwarfism|Digital arthropathy-brachydactyly, familial|Neuromuscular disease|Inborn genetic diseases|Charcot-Marie-Tooth disease|not provided|Distal spinal muscular atrophy, congenital nonprogressive	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000005000	12	110238470	12	109800665	5000	20039	rs267607144	NC_000012.12:109800664:C:T
NM_021625.5(TRPV4):c.943C>T (p.Arg315Trp)	TRPV4	R315W, R281W, R268W	Charcot-Marie-Tooth disease axonal type 2C|not provided|Autosomal dominant distal hereditary motor neuropathy|Neuromuscular disease|Scapuloperoneal spinal muscular atrophy|Distal spinal muscular atrophy, congenital nonprogressive	Pathogenic/Likely pathogenic(Last reviewed: Sep 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004999	12	110236628	12	109798823	4999	20038	rs267607143	NC_000012.12:109798822:G:A
NM_021625.5(TRPV4):c.2396C>T (p.Pro799Leu)	TRPV4	P692L, P752L, P739L, P765L	not provided|Skeletal dysplasia|Inborn genetic diseases|Spondyloepiphyseal dysplasia Maroteaux type|Metatrophic dysplasia|Parastremmatic dwarfism|Charcot-Marie-Tooth disease axonal type 2C	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004998	12	110222183	12	109784378	4998	20037	rs121912637	NC_000012.12:109784377:G:A
NM_021625.5(TRPV4):c.991A>T (p.Ile331Phe)	TRPV4	I331F, I284F, I297F	Skeletal dysplasia|Metatrophic dysplasia	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000004997	12	110236580	12	109798775	4997	20036	rs121912636	NC_000012.12:109798774:T:A
NM_021625.5(TRPV4):c.2146G>T (p.Ala716Ser)	TRPV4	A656S, A609S, A669S, A682S	Skeletal dysplasia|Spondylometaphyseal dysplasia, Kozlowski type	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000004996	12	110226267	12	109788462	4996	20035	rs121912635	NC_000012.12:109788461:C:A
NM_021625.5(TRPV4):c.998A>G (p.Asp333Gly)	TRPV4	D333G, D299G, D286G	Skeletal dysplasia|Spondylometaphyseal dysplasia, Kozlowski type	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000004995	12	110236573	12	109798768	4995	20034	rs121912634	NC_000012.12:109798767:T:C
NM_021625.5(TRPV4):c.1781G>A (p.Arg594His)	TRPV4	R534H, R487H, R547H, R560H	Charcot-Marie-Tooth disease axonal type 2C|not provided|Neuromuscular disease|Skeletal dysplasia|Metatrophic dysplasia|Spondylometaphyseal dysplasia, Kozlowski type|Parastremmatic dwarfism	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004994	12	110230500	12	109792695	4994	20033	rs77975504	NC_000012.12:109792694:C:T
NM_021625.5(TRPV4):c.1858G>A (p.Val620Ile)	TRPV4	V560I, V513I, V573I, V586I	Skeletal dysplasia|Neuromuscular disease|Skeletal dysplasia|Charcot-Marie-Tooth disease|Brachyrachia (short spine dysplasia)|not provided|Charcot-Marie-Tooth disease axonal type 2C	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004993	12	110230201	12	109792396	4993	20032	rs121912633	NC_000012.12:109792395:C:T
NM_021625.5(TRPV4):c.1847G>A (p.Arg616Gln)	TRPV4	R509Q, R569Q, R582Q, R556Q	not provided|Skeletal dysplasia|Brachyrachia (short spine dysplasia)	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000004992	12	110230212	12	109792407	4992	20031	rs121912632	NC_000012.12:109792406:C:T
NM_000371.4(TTR):c.252T>G (p.Phe84Leu)	TTR	F84L	Amyloidogenic transthyretin amyloidosis|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000845368	18	29175134	18	31595171	845368	846811	rs2073510805	NC_000018.10:31595170:T:G
NM_000371.4(TTR):c.148G>C (p.Val50Leu)	TTR	V50L	Charcot-Marie-Tooth disease|Amyloidogenic transthyretin amyloidosis	Pathogenic	criteria provided, single submitter	VCV000013440	18	29172937	18	31592974	13440	28479	rs28933979	NC_000018.10:31592973:G:C
NM_000371.4(TTR):c.424G>A (p.Val142Ile)	TTR	V142I	Amyloid Cardiomyopathy, Transthyretin-related|ATTRV122I amyloidosis|Cardiomyopathy|Cardiovascular phenotype|Dystransthyretinemic euthyroidal hyperthyroxinemia|Carpal tunnel syndrome|Amyloidogenic transthyretin amyloidosis|Charcot-Marie-Tooth disease|none provided|Postural tremor|Anemia|Bone marrow hypocellularity|Pancytopenia|not provided|Amyloidogenic transthyretin amyloidosis	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013426	18	29178618	18	31598655	13426	28465	rs76992529	NC_000018.10:31598654:G:A
NM_000371.4(TTR):c.290C>A (p.Ser97Tyr)	TTR	S97Y	Charcot-Marie-Tooth disease|not specified|not provided|Amyloidogenic transthyretin amyloidosis	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013422	18	29175172	18	31595209	13422	28461	rs121918071	NC_000018.10:31595208:C:A
NM_000371.4(TTR):c.238A>G (p.Thr80Ala)	TTR	T80A	none provided|Cardiomyopathy|Charcot-Marie-Tooth disease|not provided|Amyloidogenic transthyretin amyloidosis	Pathogenic(Last reviewed: Apr 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013421	18	29175120	18	31595157	13421	28460	rs121918070	NC_000018.10:31595156:A:G
NM_000371.4(TTR):c.148G>A (p.Val50Met)	TTR	V50M	none provided|Charcot-Marie-Tooth disease|Dystransthyretinemic euthyroidal hyperthyroxinemia|Amyloidogenic transthyretin amyloidosis|Carpal tunnel syndrome|not provided|Amyloidogenic transthyretin amyloidosis|Cardiomyopathy	Pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013417	18	29172937	18	31592974	13417	28456	rs28933979	NC_000018.10:31592973:G:A
NM_003680.4(YARS1):c.586G>C (p.Glu196Gln)	YARS1	E196Q	Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000243071	1	33263369	1	32797768	243071	244151	rs121908834	NC_000001.11:32797767:C:G
NM_003680.4(YARS1):c.586G>A (p.Glu196Lys)	YARS1	E196K	Charcot-Marie-Tooth disease, dominant intermediate C|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000006189	1	33263369	1	32797768	6189	21228	rs121908834	NC_000001.11:32797767:C:T
